morp,morp_desen,behaviour,o3site,icd10,comments
8000/1/1,"Neoplasm, uncertain whether benign or malignant",Borderline,Specific Sites,See Topo Table B Col F,
8000/2/1,"Neoplasm, in situ",In-Situ,Specific Sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8000/3/1,"Neoplasm, malignant",Malignant,Specific Sites,See Topo Table B Col B,
8000/6/1,"Neoplasm, metastatic",Metastatic,Specific Sites,See Topo Table B Col C,Not a code used in the registry
8000/9/1,"Neoplasm, malignant, uncertain whether primary or metastatic (C809)",Unknown,C809,C80,Not a code used in the registry
8001/1/1,"Tumor cells, uncertain whether benign or malignant",Borderline,Specific Sites,See Topo Table B Col F,
8001/3/1,"Tumor cells, malignant",Malignant,Specific Sites,See Topo Table B Col B,
8002/3/1,"Malignant tumor, small cell type",Malignant,Specific Sites,See Topo Table B Col B,
8003/3/1,"Malignant tumor, giant cell type",Malignant,Specific Sites,See Topo Table B Col B,
8004/3/1,"Malignant tumor, spindle cell type",Malignant,Specific Sites,See Topo Table B Col B,
8005/3/1,"Malignant tumor, clear cell type",Malignant,Specific Sites,See Topo Table B Col B,
8010/2/1,"Carcinoma in situ, NOS",In-Situ,Specific Sites,See Topo Table B Col D,
8010/3/1,"Carcinoma, NOS",Malignant,Specific Sites,See Topo Table B Col B,
8010/6/1,"Carcinoma, metastatic, NOS",Metastatic,Specific Sites,See Topo Table B Col C,Not a code used in the registry
8010/9/1,Carcinomatosis (C809),Unknown,C809,C80,Not a code used in the registry
8011/3/1,"Epithelioma, malignant",Malignant,Specific Sites,See Topo Table B Col B,
8012/2/1,"Large cell carcinoma, in situ",In-Situ,Specific Sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8012/3/1,"Large cell carcinoma, NOS",Malignant,Specific Sites,See Topo Table B Col B,
8013/3/1,Large cell neuroendocrine carcinoma,Malignant,Specific Sites,See Topo Table B Col B,
8014/3/1,Large cell carcinoma with rhabdoid phenotype,Malignant,Specific Sites,See Topo Table B Col B,
8015/3/1,Glassy cell carcinoma,Malignant,Specific Sites,See Topo Table B Col B,
8020/2/1,"Carcinoma, undifferentiated, NOS, in situ",In-Situ,Specific Sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8020/3/1,"Carcinoma, undifferentiated, NOS",Malignant,Specific Sites,See Topo Table B Col B,
8021/3/1,"Carcinoma, anaplastic, NOS",Malignant,Specific Sites,See Topo Table B Col B,
8022/2/1,Pleomorphic carcinoma in situ,In-Situ,Specific Sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8022/3/1,Pleomorphic carcinoma,Malignant,Specific Sites,See Topo Table B Col B,
8023/3/1,Nuclear protein in testis (NUT) associated carcinoma (ICD-O-3.2 update),Malignant,Specific Sites,See Topo Table B Col B,
8030/2/1,Spindle cell carcinoma in situ,In-Situ,Specific Sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8030/3/1,Giant cell and spindle cell carcinoma,Malignant,Specific Sites,See Topo Table B Col B,
8031/3/1,Giant cell carcinoma,Malignant,Specific Sites,See Topo Table B Col B,
8032/2/1,Spindle cell carcinoma in situ,In-Situ,Specific Sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8032/3/1,"Spindle cell carcinoma, NOS",Malignant,Specific Sites,See Topo Table B Col B,
8033/2/1,"Pseudosarcomatous carcinoma, in situ",In-Situ,Specific Sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8033/3/1,Pseudosarcomatous carcinoma,Malignant,Specific Sites,See Topo Table B Col B,
8034/3/1,Polygonal cell carcinoma,Malignant,Specific Sites,See Topo Table B Col B,
8035/3/1,Carcinoma with osteoclast-like giant cells,Malignant,Specific Sites,See Topo Table B Col B,
8040/1/1,"Tumorlet, NOS",Borderline,Specific Sites,See Topo Table B Col F,
8040/3/1,"Tumorlet, malignant",Malignant,Specific Sites,See Topo Table B Col B,Not listed in ICD-O-3.2
8041/2/1,"Small cell carcinoma, in situ",In-Situ,Specific Sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8041/3/1,"Small cell carcinoma, NOS",Malignant,Specific Sites,See Topo Table B Col B,
8042/3/1,Oat cell carcinoma  (C34_),Malignant,"C349, All Other Sites","C34.9, See Topo Table B Col B",
8043/3/1,"Small cell carcinoma, fusiform cell (C34_)",Malignant,"C349, All Other Sites","C34.9, See Topo Table B Col B",
8044/3/1,"Small cell carcinoma, intermediate cell (C34_)",Malignant,"C349, All Other Sites","C34.9, See Topo Table B Col B",
8045/2/1,"Combined small cell carcinoma, in situ (C34_)",In-Situ,"C349, All Other Sites","D02.2, See Topo Table B Col D",Not listed in ICD-O-3.2
8045/3/1,Combined small cell carcinoma (C34_),Malignant,"C349, All Other Sites","C34.9, See Topo Table B Col B",
8046/2/1,Non-small cell carcinoma in situ  (C34_),In-Situ,"C349, All Other Sites","D02.2, See Topo Table B Col D",Not listed in ICD-O-3.2
8046/3/1,Non-small cell carcinoma  (C34_),Malignant,"C349, All Other Sites","C34.9, See Topo Table B Col B",
8050/1/1,Papilloma of uncertain malignant potential,Borderline,Specific Sites,See Topo Table B Col F,Not listed in ICD-O-3.2
8050/2/1,Papillary carcinoma in situ,In-Situ,Specific Sites,See Topo Table B Col D,
8050/3/1,"Papillary carcinoma, NOS",Malignant,Specific Sites,See Topo Table B Col B,
8051/2/1,Verrucous carcinoma in situ,In-Situ,Specific sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8051/3/1,"Verrucous carcinoma, NOS",Malignant,Specific Sites,See Topo Table B Col B,
8052/2/1,"Papillary squamous cell carcinoma, non-invasive",In-Situ,Specific sites,See Topo Table B Col D,
8052/3/1,Papillary squamous cell carcinoma,Malignant,Specific Sites,See Topo Table B Col B,
8053/2/1,"Squamous cell papilloma, inverted, in situ",In-Situ,Specific sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8053/3/1,"Squamous cell papilloma, inverted, malignant",Malignant,Specific Sites,See Topo Table B Col B,Not listed in ICD-O-3.2
8054/3/1,Warty carcinoma (ICD-O-3.2 update),Malignant,Specific Sites,See Topo Table B Col B,
8060/3/1,"Papillomatosis, NOS, malignant",Malignant,Specific Sites,See Topo Table B Col B,Not listed in ICD-O-3.2
8070/2/1,"Squamous cell carcinoma in situ, NOS",In-Situ,Specific Sites,See Topo Table B Col D,
8070/3/1,"Squamous cell carcinoma, NOS",Malignant,Specific Sites,See Topo Table B Col B,
8070/6/1,"Squamous cell carcinoma, metastatic, NOS",Metastatic,Specific Sites,See Topo Table B Col C,Not a code used in the registry
8071/2/1,Differentiated intraepithelial neoplasia,In-Situ,Specific Sites,See Topo Table B Col D,
8071/3/1,"Squamous cell carcinoma, keratinizing, NOS",Malignant,Specific Sites,See Topo Table B Col B,
8072/2/1,"Squamous cell carcinoma, large cell, nonkeratinizing, in situ",In-Situ,Specific Sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8072/3/1,"Squamous cell carcinoma, large cell, nonkeratinizing, NOS",Malignant,Specific Sites,See Topo Table B Col B,
8073/2/1,"Squamous cell carcinoma, small cell, nonkeratinizing, in situ",In-Situ,Specific Sites,See Topo Table B Col D,
8073/3/1,"Squamous cell carcinoma, small cell, nonkeratinizing",Malignant,Specific Sites,See Topo Table B Col B,
8074/3/1,"Squamous cell carcinoma, spindle cell",Malignant,Specific Sites,See Topo Table B Col B,
8075/2/1,"Squamous cell carcinoma, adenoid, in situ",In-Situ,Specific Sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8075/3/1,"Squamous cell carcinoma, adenoid",Malignant,Specific Sites,See Topo Table B Col B,
8076/2/1,Squamous cell CIS with questionable stromal invasion (C53_),In-Situ,"C539, All Other Sites","D06.9, See Topo Table B Col D",
8076/3/1,"Squamous cell carcinoma, micro-invasive",Malignant,Specific Sites,See Topo Table B Col B,
8077/2/1,"Squamous intraepithelial neoplasia, high grade",In-Situ,Specific sites,See Topo Table B Col D,
8078/3/1,Squamous cell carcinoma with horn formation,Malignant,Specific Sites,See Topo Table B Col B,
8080/2/1,Queyrat erythroplasia (C60_),In-Situ,"C609, All Other Sites","D07.4, See Topo Table B Col D",
8080/3/1,"Queyrat erythroplasia, malignant (C60_)",Malignant,"C609, All Other Sites","C60.9, See Topo Table B Col B",Not listed in ICD-O-3.2
8081/2/1,Bowen disease (C44_),In-Situ,"C449, All Other Sites","D04.9, See Topo Table B Col D",
8081/3/1,"Bowen's disease, malignant (C44_)",Malignant,"C449, All Other Sites","C44.9, See Topo Table B Col B",Not listed in ICD-O-3.2
8082/3/1,Lymphoepithelial carcinoma,Malignant,Specific Sites,See Topo Table B Col B,
8083/2/1,Basaloid squamous cell carcinoma in situ,In-Situ,Specific Sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8083/3/1,Basaloid squamous cell carcinoma,Malignant,Specific Sites,See Topo Table B Col B,
8084/3/1,"Squamous cell carcinoma, clear cell type",Malignant,Specific Sites,See Topo Table B Col B,
8085/3/1,"Squamous cell carcinoma, HPV-positive (ICD-O-3.2 update)",Malignant,Specific Sites,See Topo Table B Col B,
8086/3/1,"Squamous cell carcinoma, HPV-negative (ICD-O-3.2 update)",Malignant,Specific Sites,See Topo Table B Col B,
8090/1/1,Basal cell tumor (C44_),Borderline,"C449, All Other Sites","D48.5, See Topo Table B Col F",
8090/2/1,Basal cell carcinoma in situ (C44_),In-Situ,"C449, All Other Sites","D04.9, See Topo Table B Col D",Not listed in ICD-O-3.2
8090/3/1,"Basal cell carcinoma, NOS (C44_)",Malignant,"C449, All Other Sites","C44.9, See Topo Table B Col B",
8091/2/1,"Multicentric basal cell carcinoma, in situ (C44_)",In-Situ,"C449, All Other Sites","D04.9, See Topo Table B Col D",Not listed in ICD-O-3.2
8091/3/1,Superficial basal cell carcinoma (C44_),Malignant,"C449, All Other Sites","C44.9, See Topo Table B Col B",
8092/3/1,"Infiltrating basal cell carcinoma, NOS (C44_)",Malignant,"C449, All Other Sites","C44.9, See Topo Table B Col B",
8093/3/1,"Basal cell carcinoma, fibroepithelial (C44_)",Malignant,"C449, All Other Sites","C44.9, See Topo Table B Col B",
8094/2/1,Basosquamous carcinoma in situ (C44),In-Situ,"C449, All Other Sites","D04.9, See Topo Table B Col D",Not listed in ICD-O-3.2
8094/3/1,Basosquamous carcinoma (C44_),Malignant,"C449, All Other Sites","C44.9, See Topo Table B Col B",
8095/3/1,Metatypical carcinoma (C44_),Malignant,"C449, All Other Sites","C44.9, See Topo Table B Col B",
8097/3/1,"Basal cell carcinoma, nodular (C44_)",Malignant,"C449, All Other Sites","C44.9, See Topo Table B Col B",
8098/3/1,Adenoid basal cell carcinoma (C53_),Malignant,"C539, All Other Sites","C539, See Topo Table B Col B",
8100/3/1,Trichoblastic carcinoma (ICD-O-3.2 update) (C44_),Malignant,"C449, All Other Sites","C44.9, See Topo Table B Col B",
8102/3/1,Trichilemmocarcinoma (C44_),Malignant,"C449, All Other Sites","C44.9, See Topo Table B Col B",
8103/1/1,Proliferating trichilemmal cyst (C44_) (ICD-O-3.2 update),Borderline,"C449, All Other Sites","D48.5, See Topo Table B Col F",
8103/3/1,"Pilar tumor, malignant (C44_)",Malignant,"C449, All Other Sites","C44.9, See Topo Table B Col B",Not listed in ICD-O-3.2
8110/3/1,Pilomatrical carcinoma (C44_),Malignant,"C449, All Other Sites","C44.9, See Topo Table B Col B",
8120/1/1,"Urothelial papilloma, NOS (C67_) (ICD-O-3.2 update, see code 8210/0)",Borderline,"C679, All Other Sites","D41.4, See Topo Table B Col F",
8120/2/1,Urothelial carcinoma in situ (C67_),In-Situ,"C679, All Other Sites","D09.0, See Topo Table B Col D",
8120/3/1,"Transitional cell carcinoma, NOS (C67_)",Malignant,"C679, All Other Sites","C67.9, See Topo Table B, Col B",
8121/1/1,"Sinonasal papilloma, inverted, NOS (C300, C31_) (ICD-O-3.2 update, see code 8120/0)",Borderline,"C300, C319, All Other Sites","D38.5, See Topo Table B Col F",
8121/2/1,"Transitional cell carcinoma in situ, inverted, NOS (C300, C31_)",In-Situ,"C300, C319, All Other Sites","D02.3, See Topo Table B Col D",
8121/3/1,"Schneiderian carcinoma (C300, C31_)",Malignant,"C300, C319, All Other Sites","C30.0, C31.9, See Topo Table B Col B",
8122/2/1,"Transitional cell carcinoma, spindle cell, in situ",In-Situ,Specific sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8122/3/1,"Urothelial carcinoma, sarcomatoid",Malignant,Specific Sites,See Topo Table B Col B,
8123/2/1,"Basaloid carcinoma, in situ (C211)",In-Situ,"C211, All Other Sites","D01.3, See Topo Table B Col D",Not listed in ICD-O-3.2
8123/3/1,Basaloid carcinoma (C211),Malignant,"C211, All Other Sites","C21.1, See Topo Table B Col B",
8124/2/1,Cloacogenic carcinoma in situ (C212),In-Situ,"C212, All Other Sites","D01.3, See Topo Table B Col D",Not listed in ICD-O-3.2
8124/3/1,Cloacogenic carcinoma (C212),Malignant,"C212, All Other Sites","C21.2, See Topo Table B Col B",
8130/1/1,Papillary urothelial neoplasm of low malignant potential (C67_),Borderline,"C679, All Other Sites","D41.4, See Topo Table B Col F",
8130/2/1,"Papillary urothelial carcinoma, non-invasive (C67_)",In-Situ,"C679, All Other Sites","D09.0, See Topo Table B Col D",
8130/3/1,Papillary transitional cell carcinoma  (C67_),Malignant,"C679, All Other Sites","C67.9, See Topo Table B, Col B",
8131/2/1,"Urothelial carcinoma in situ, micropapillary (C67_)",In-Situ,"C679, All Other Sites","D09.0, See Topo Table B Col D",Not listed in ICD-O-3.2
8131/3/1,"Urothelial carcinoma, micropapillary (C67_)",Malignant,"C679, All Other Sites","C67.9, See Topo Table B, Col B",
8140/1/1,Atypical adenoma (C34_),Borderline,"C349, All Other Sites","D38.1, See Topo Table B Col F",
8140/2/1,"Adenocarcinoma in situ, NOS",In-Situ,Specific Sites,See Topo Table B Col D,
8140/3/1,"Adenocarcinoma, NOS",Malignant,Specific Sites,See Topo Table B Col B,
8140/6/1,"Adenocarcinoma, metastatic, NOS",Metastatic,Specific Sites,See Topo Table B Col C,Not a code used in the registry
8141/3/1,Scirrhous adenocarcinoma,Malignant,Specific Sites,See Topo Table B Col B,
8142/3/1,Linitis plastica (C16_),Malignant,"C169, All Other Sites","C16.9, See Topo Table B Col B",
8143/2/1,Superficial spreading adenocarcinoma in situ,In-Situ,Specific sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8143/3/1,Superficial spreading adenocarcinoma,Malignant,Specific Sites,See Topo Table B Col B,
8144/2/1,"Intestinal-type adenoma, high grade (C16_)",In-Situ,"C169, All Other Sites","D00.2, See Topo Table B Col D",Not listed in ICD-O-3.2
8144/3/1,"Adenocarcinoma, intestinal type (C16_)",Malignant,"C169, All Other Sites","C16.9, See Topo Table B Col B",
8145/2/1,"Carcinoma in situ, diffuse type (C16_)",In-Situ,"C169, All Other Sites","D00.2, See Topo Table B Col D",Not listed in ICD-O-3.2
8145/3/1,"Carcinoma, diffuse type  (C16_)",Malignant,"C169, All Other Sites","C16.9, See Topo Table B Col B",
8146/3/1,Monomorphic adenocarcinoma,Malignant,Specific Sites,See Topo Table B Col B,Not listed in ICD-O-3.2
8147/2/1,"Basal cell adenocarcinoma in situ (C07_, C08_)",In-Situ,"C079, C089, All Other Sites","D00.0, See Topo Table B Col D",Not listed in ICD-O-3.2
8147/3/1,"Basal cell adenocarcinoma (C07_, C08_)",Malignant,"C079, C089, All Other Sites","C07, C08.9, See Topo Table B Col B",
8148/2/1,"Glandular intraepithelial neoplasia, high grade (PIN III) (C619)",In-Situ,"C619, All Other Sites","D07.5, See Topo Table B Col D",
8148/3/1,"Glandular intraepithelial neoplasia, malignant, high grade (PIN III) (C619)",Malignant,"C619, All Other Sites","C61, See Topo Table B, Col B",Not listed in ICD-O-3.2
8149/3/1,Canalicular adenocarcinoma,Malignant,Specific Sites,See Topo Table B Col B,Not listed in ICD-O-3.2
8150/1/1,"Pancreatic endocrine tumor, NOS (C25_) (ICD-O-3.2 update, see code 8150/3)",Borderline,"C259, All Other Sites","D37.7, See Topo Table B Col F",
8150/3/1,"Pancreatic neuroendocrine tumor, nonfunctioning (C254)  (ICD-O-3 update, previously 8150/0, 8150/1)",Malignant,"C254, All Other Sites","C25.4, See Topo Table B Col B",
8151/3/1,"Insulinoma, malignant (C254) (ICD-O-3.2 update, previously 8151/0)",Malignant,"C254, All Other Sites","C25.4, See Topo Table B Col B",
8152/1/1,"Glucagonoma, NOS (C25_) (ICD-O-3.2 update, see code 8152/3)",Borderline,"C259, All Other Sites","D37.7, See Topo Table B Col F",
8152/3/1,"Glucagonoma, NOS (C25_) (ICD-O-3 update, previusly 8152/1))",Malignant,"C259, All Other Sites","C25.4, See Topo Table B Col B",
8153/1/1,"Gastrinoma, NOS (C254) (ICD-O-3.2 update, see code 8153/3)",Borderline,"C254, All Other Sites","D37.7, See Topo Table B Col F",
8153/3/1,"Gastrinoma, NOS (C25_) (ICD-O-3 update, previously 8153/1)",Malignant,"C259, All Other Sites","C25.9, See Topo Table B Col B",
8154/3/1,Mixed neuroendocrine non-neuroendocrine neoplasm (MiNEN) (C25_)  (ICD-O-3 updated),Malignant,"C259, All Other Sites","C25.9, See Topo Table B Col B",
8155/1/1,"Vipoma, NOS (ICD-O-3.2 update, see code 8155/3)",Borderline,Specific Sites,See Topo Table B Col F,
8155/3/1,"Vipoma, NOS (C25_)  (ICD-O-3 update, previously 8155/1))",Malignant,"C259, All Other Sites","C25.9, See Topo Table B Col B",
8156/1/1,"Somatostatinoma, NOS (C25_) (ICD-O-3.2 update, see code 8156/3)",Borderline,"C259, All Other Sites","D37.7, See Topo Table B Col F",
8156/3/1,"Somatostatinoma, NOS (C25_)  (ICD-O-3 update, previously 8156/1)",Malignant,"C259, All Other Sites","C25.9, See Topo Table B Col B",
8158/1/1,"ACTH-producing tumor, borderline (ICD-O-3 update, moved to 8158/3)",Borderline,Specific Sites,See Topo Table B Col F,
8158/3/1,"ACTH-producing tumor (C25_) (ICD-O-3 update, 8158/1 moved to this code)",Malignant,"C259, All Other Sites","C25.9, See Topo Table B Col B",
8160/2/1,"Bile duct adenocarcinoma in situ (C221, C240)",In-Situ,"C221, C240, All Other Sites","D01.5, See Topo Table B Col D",Not listed in ICD-O-3.2
8160/3/1,"Cholangiocarcinoma (C221, C240)",Malignant,"C221, C240, All Other Sites","C22.1, C24.0, See Topo Table B Col B",
8161/3/1,"Bile duct cystadenocarcinoma (C221, C240)",Malignant,"C221, C240, All Other Sites","C22.1, C24.0, See Topo Table B Col B",
8162/2/1,"Klatskin tumor, in situ (C221, C240)",In-Situ,"C221, C240, All Other Sites","D01.5, See Topo Table B Col D",Not listed in ICD-O-3.2
8162/3/1,"Klatskin tumor (C221, C240)",Malignant,"C221, C240, All Other Sites","C22.1, C24.0, See Topo Table B Col B",
8163/2/1,"Papillary neoplasm, pancreatobiliary-type, with high grade intraepithelial neoplasia (C241)",In-Situ,"C241, All Other Sites","D01.5, See Topo Table B Col D",
8163/3/1,Pancreatobiliary-type carcinoma (C241),Malignant,"C241, All Other Sites","C24.1, See Topo Table B Col B",
8170/2/1,Hepatocellular carcinoma in situ (C220),In-Situ,"C220, All Other Sites","D01.5, See Topo Table B Col D",Not listed in ICD-O-3.2
8170/3/1,"Hepatocellular carcinoma, NOS (C220)",Malignant,"C220, All Other Sites","C22.0, See Topo Table B Col B",
8171/3/1,"Hepatocellular carcinoma, fibrolamellar (C220)",Malignant,"C220, All Other Sites","C22.0, See Topo Table B Col B",
8172/3/1,"Hepatocellular carcinoma, scirrhous (C220)",Malignant,"C220, All Other Sites","C22.0, See Topo Table B Col B",
8173/3/1,"Hepatocellular carcinoma, spindle cell variant (C220)",Malignant,"C220, All Other Sites","C22.0, See Topo Table B Col B",
8174/3/1,"Hepatocellular carcinoma, clear cell type (C220)",Malignant,"C220, All Other Sites","C22.0, See Topo Table B Col B",
8175/3/1,"Hepatocellular carcinoma, pleomorphic type (C220)",Malignant,"C220, All Other Sites","C22.0, See Topo Table B Col B",
8180/2/1,"Combined hepatocellular carcinoma and cholangiocarcinoma, in situ (C220)",In-Situ,"C220, All Other Sites","D01.5, See Topo Table B Col D",Not listed in ICD-O-3.2
8180/3/1,Combined hepatocellular carcinoma and cholangiocarcinoma (C220),Malignant,"C220, All Other Sites","C22.0, See Topo Table B Col B",
8190/3/1,Trabecular adenocarcinoma,Malignant,Specific Sites,See Topo Table B Col B,
8200/2/1,Adenoid cystic carcinoma in situ (C44_),In-Situ,"C449, All Other Sites","D04.9, See Topo Table B Col D",Not listed in ICD-O-3.2
8200/3/1,Adenoid cystic carcinoma (C44_),Malignant,"C449, All Other Sites","C44.9, See Topo Table B Col B",
8201/2/1,Cribriform carcinoma in situ (C50_),In-Situ,"C509, All Other Sites","D05.8, See Topo Table B Col D",
8201/3/1,"Cribriform carcinoma, NOS  (C50_)",Malignant,"C509, All Other Sites","C50.9, See Topo Table B Col B",
8210/2/1,Adenocarcinoma in situ in adenomatous polyp,In-Situ,Specific Sites,See Topo Table B Col D,
8210/3/1,Adenocarcinoma in adenomatous polyp,Malignant,Specific Sites,See Topo Table B Col B,
8211/2/1,Tubular adenocarcinoma in situ,In-Situ,Specific Sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8211/3/1,Tubular adenocarcinoma (C44_),Malignant,"C449, All Other Sites","C44.9, See Topo Table B Col B",
8212/2/1,"Flat adenoma, in situ",In-Situ,Specific sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8212/3/1,"Flat adenoma, malignant",Malignant,Specific Sites,See Topo Table B Col B,Not listed in ICD-O-3.2
8213/2/1,"Serrated adenoma, in situ (C18_)",In-Situ,"C189, All Other Sites","D01.0, See Topo Table B Col D",Not listed in ICD-O-3.2
8213/3/1,Serrated adenocarcinoma,Malignant,Specific Sites,See Topo Table B Col B,
8214/3/1,Parietal cell carcinoma (C16_),Malignant,"C169, All Other Sites","C16.9, See Topo Table B Col B",
8215/2/1,"Adenocarcinoma of anal glands, in situ (C211)",In-Situ,"C211, All Other Sites","D01.3, See Topo Table B Col D",Not listed in ICD-O-3.2
8215/3/1,Adenocarcinoma of anal glands (C211),Malignant,"C211, All Other Sites","C21.1, See Topo Table B Col B",
8220/2/1,Adenocarcinoma in situ in adenomatous polyposis coli (C18_),In-Situ,"C189, All Other Sites","D01.0, See Topo Table B Col D",Not listed in ICD-O-3.2
8220/3/1,Adenocarcinoma in adenomatous polyposis coli (C18_),Malignant,"C189, All Other Sites","C18.9, See Topo Table B Col B",
8221/2/1,Adenocarcinoma in situ in multiple adenomatous polyposis coli,In-Situ,Specific sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8221/3/1,Adenocarcinoma in multiple adenomatous polyposis coli,Malignant,Specific Sites,See Topo Table B Col B,
8230/2/1,"Ductal carcinoma in situ, solid type (C50_)",In-Situ,"C509, All Other Sites","D05.9, See Topo Table B Col D",
8230/3/1,"Solid carcinoma, NOS (C50_)",Malignant,"C509, All Other Sites",See Topo Table B Col B,
8231/3/1,Carcinoma simplex,Malignant,Specific Sites,See Topo Table B Col B,
8240/1/1,"Carcinoid tumor of uncertain malignant potential (ICD-O-3 update, see 8241/3)",Borderline,Specific Sites,See Topo Table B Col F,
8240/2/1,"Carcinoid tumor, in situ (C181)",In-Situ,"C181, All Other Sites","D01.0, See Topo Table B Col D",Not listed in ICD-O-3.2
8240/3/1,"Neuroendocrine tumor, NOS (ICD-O-3 update, previously 8240/1)",Malignant,Specific Sites,See Topo Table B Col B,
8241/3/1,"Enterochromaffin cell carcinod (ICD-O-3.2, 8240/1 moved to this code)",Malignant,Specific Sites,See Topo Table B Col B,
8242/1/1,"Enterochromaffin-like cell carcinoid, NOS (ICD-O-3.2 update, code moved to 8242/3)",Borderline,Specific Sites,See Topo Table B Col F,
8242/3/1,"Enterochromaffin-like cell tumor, malignant (ICD-O-3 update, previously 8242/1)",Malignant,Specific Sites,See Topo Table B Col B,Not listed in ICD-O-3.2
8243/2/1,"Goblet cell carcinoid, in situ",In-Situ,Specific sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8243/3/1,Goblet cell carcinoid,Malignant,Specific Sites,See Topo Table B Col B,
8244/2/1,"Mixed adenoneuroendocrine carcinoma, in situ (ICD-O-3 update)",In-Situ,Specific Sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8244/3/1,Mixed adenoneuroendocrine carcinoma,Malignant,Specific Sites,See Topo Table B Col B,
8245/1/1,Tubular carcinoid,Borderline,Specific Sites,See Topo Table B Col F,
8245/2/1,"Adenocarcinoid tumor, in situ",In-Situ,Specific sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8245/3/1,Adenocarcinoid tumor,Malignant,Specific Sites,See Topo Table B Col B,
8246/2/1,Neuroendocrine carcinoma in situ,In-Situ,Specific Sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8246/3/1,"Neuroendocrine carcinoma, NOS",Malignant,Specific Sites,See Topo Table B Col B,
8247/2/1,"Merkel cell carcinoma, in situ (C44_)",In-Situ,"C449, All Other Sites","D04.9, See Topo Table B Col D",Not listed in ICD-O-3.2
8247/3/1,Merkel cell carcinoma (C44_),Malignant,"C449, All Other Sites","C44.9, See Topo Table B Col B",
8248/1/1,Apudoma,Borderline,Specific Sites,See Topo Table B Col F,
8249/3/1,"Neuroendocrine tumor, grade 2",Malignant,Specific Sites,See Topo Table B Col B,
8250/1/1,Pulmonary adenomatosis (C34_),Borderline,"C349, All Other Sites","D38.1, See Topo Table B Col F",
8250/2/1,"Adenocarcinoma in situ of the lung, non-mucinous (C34)",In-Situ,"C349, All Other Sites","D02.2, See Topo Table B Col D",
8250/3/1,Lepidic adenocarcinoma (C34_),Malignant,"C349, All Other Sites","C34.9, See Topo Table B Col B",
8251/3/1,Alveolar adenocarcinoma (C34_),Malignant,"C349, All Other Sites","C34.9, See Topo Table B Col B",
8252/2/1,"Bronchio-alveolar carcinoma, non-mucinous in situ (C34_)",In-Situ,"C349, All Other Sites","D02.2, See Topo Table B Col D",Not listed in ICD-O-3.2
8252/3/1,"Bronchio-alveolar carcinoma, non-mucinous (C34_)",Malignant,"C349, All Other Sites","C34.9, See Topo Table B Col B",
8253/2/1,"Adenocarcinoma in situ of the lung, mucinous (C34_)",In-Situ,"C349, All Other Sites","D02.2, See Topo Table B Col D",
8253/3/1,"Adenocarcinoma of the lung, mucinous (C34_)",Malignant,"C349, All Other Sites","C34.9, See Topo Table B Col B",
8254/3/1,"Adenocarcinoma of the lung, mixed mucinous and non-mucinous (C34_)",Malignant,"C349, All Other Sites","C34.9, See Topo Table B Col B",
8255/2/1,"Adenocarcinoma with mixed subtypes, in situ",In-Situ,Specific Sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8255/3/1,Adenocarcinoma with mixed subtypes,Malignant,Specific Sites,See Topo Table B Col B,
8256/3/1,"Minimally invasive adenocarcinoma, non-mucinous (C34_) (ICD-O-3.2 update)",Malignant,"C349, All Other Sites","C34.9, See Topo Table B Col B",
8257/3/1,"Minimally invasive adenocarcinoma, mucinous (C34_) (ICD-O-3.2 update)",Malignant,"C349, All Other Sites","C34.9, See Topo Table B Col B",
8260/1/1,Aggressive papillary tumor (ICD-O-3.2 update),Borderline,Specific Sites,See Topo Table B Col F,
8260/2/1,"Papillary adenocarcinoma in situ, NOS",In-Situ,Specific Sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8260/3/1,"Papillary adenocarcinoma, NOS",Malignant,Specific Sites,See Topo Table B Col B,
8261/2/1,Adenocarcinoma in situ in villous adenoma,In-Situ,Specific Sites,See Topo Table B Col D,
8261/3/1,Adenocarcinoma in villous adenoma,Malignant,Specific Sites,See Topo Table B Col B,
8262/2/1,Villous adenocarcinoma in situ,In-Situ,Specific Sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8262/3/1,Villous adenocarcinoma,Malignant,Specific Sites,See Topo Table B Col B,
8263/2/1,Adenocarcinoma in situ in tubulovillous adenoma,In-Situ,Specific Sites,See Topo Table B Col D,
8263/3/1,Adenocarcinoma in tubulovillous adenoma,Malignant,Specific Sites,See Topo Table B Col B,
8264/3/1,"Papillomatosis, glandular, malignant (C221, C240)",Malignant,"C221, C240, All Other Sites","C22.1, C24.0, See Topo Table B Col B",Not listed in ICD-O-3.2
8265/3/1,"Micropapillary carcinoma, NOS (C18_)",Malignant,"C189, All Other Sites","C18.9, See Topo Table B Col B",
8270/1/1,"Chromophobe adenoma, borderline (C751)",Borderline,"C751, All Other Sites","D44.3, See Topo Table B Col F",Not listed in ICD-O-3.2
8270/3/1,Chromophobe carcinoma (C751),Malignant,"C751, All Other Sites","C75.1, See Topo Table B Col B",
8271/3/1,"Prolactinoma, malignant (C751)",Malignant,"C751, All Other Sites","C75.1, See Topo Table B Col B",Not listed in ICD-O-3.2
8272/1/1,"Pituitary, borderline malignancy (C751)",Borderline,"C751, All Other Sites","D44.3, See Topo Table B Col F",Not listed in ICD-O-3.2
8272/3/1,"Pituitary carcinoma, NOS (C751)",Malignant,"C751, All Other Sites","C75.1, See Topo Table B Col B",
8273/3/1,Pituitary blastoma (ICD-O-3.2 update) (C751),Malignant,"C751, All Other Sites","C75.1, See Topo Table B Col B",
8280/3/1,Acidophil carcinoma (C751),Malignant,"C751, All Other Sites","C75.1, See Topo Table B Col B",
8281/3/1,Mixed acidophil-basophil carcinoma (C751),Malignant,"C751, All Other Sites","C75.1, See Topo Table B Col B",
8290/2/1,Oxyphillic adenocarcinoma in situ (C739),In-Situ,"C739, All Other Sites","D09.3, See Topo Table B Col D",Not listed in ICD-O-3.2
8290/3/1,Oxyphillic adenocarcinoma (C739),Malignant,"C739, All Other Sites","C73, See Topo Table B Col B",
8300/3/1,Basophil carcinoma (C751),Malignant,"C751, All Other Sites","C75.1, See Topo Table B Col B",
8310/2/1,Clear cell adenocarcinoma in situ,In-Situ,Specific Sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8310/3/1,"Clear cell adenocarcinoma, NOS",Malignant,Specific Sites,See Topo Table B Col B,
8311/1/1,Hypernephroid tumor [obs] (C649),Borderline,Specific Sites,See Topo Table B Col F,
8311/3/1,Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome-associated renal cell carcinoma (C649),Malignant,"C649, All Other Sites","C64, See Topo Table B Col B",
8312/2/1,Renal cell carcinoma in situ (C649),In-Situ,"C649, All Other Sites","D09.1, See Topo Table B Col D",Not listed in ICD-O-3.2
8312/3/1,Renal cell carcinoma (C649),Malignant,"C649, All Other Sites","C64, See Topo Table B Col B",
8313/1/1,"Clear cell borderline tumor (C569) (ICD-O-3 update, previously 8444/1)",Borderline,"C569, All Other Sites","D39.1, See Topo Table B Col F",
8313/3/1,"Clear cell adenocarcinofibroma (C569) (ICD-O-3 update, previously 8444/3)",Malignant,"C569, All Other Sites","C56, See Topo Table B Col B",
8314/3/1,Lipid-rich carcinoma (C50_),Malignant,"C509, All Other Sites","C50.9, See Topo Table B Col B",
8315/3/1,Glycogen-rich carcinoma (C50_),Malignant,"C509, All Other Sites","C50.9, See Topo Table B Col B",
8316/1/1,Multilocular cystic renal neoplasm of low malignant potential (C649) (ICD-O-3.2 update),Borderline,"C649, All Other Sites","D41.0, See Topo Table B Col F",
8316/2/1,"Cyst-associated renal cell carcinoma, in situ (C649)",In-Situ,"C649, All Other Sites","D09.1, See Topo Table B Col D",Not listed in ICD-O-3.2
8316/3/1,Cyst-associated renal cell carcinoma  (C649),Malignant,"C649, All Other Sites","C64, See Topo Table B Col B",
8317/3/1,"Renal cell carcinoma, chromophobe type (C649)",Malignant,"C649, All Other Sites","C64, See Topo Table B Col B",
8318/3/1,"Renal cell carcinoma, sarcomatoid (C649)",Malignant,"C649, All Other Sites","C64, See Topo Table B Col B",
8319/2/1,Collecting duct carcinoma in situ (C649),In-Situ,"C649, All Other Sites","D09.1, See Topo Table B Col D",Not listed in ICD-O-3.2
8319/3/1,Collecting duct carcinoma (C649),Malignant,"C649, All Other Sites","C64, See Topo Table B Col B",
8320/3/1,Granular cell carcinoma,Malignant,Specific Sites,See Topo Table B Col B,
8322/3/1,Water-clear cell adenocarcinoma (C750),Malignant,"C750, All Other Sites","C75.0, See Topo Table B Col B",
8323/1/1,Clear cell papillary renal cell carcinoma (C649) (ICD-O-3.2 update),Borderline,"C649, All Other Sites","D41.0, See Topo Table B Col F",
8323/2/1,Mixed cell adenocarcinoma in situ,In-Situ,Specific Sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8323/3/1,Mixed cell adenocarcinoma,Malignant,Specific Sites,See Topo Table B Col B,
8325/3/1,Metanephric adenocarcinoma (C649),Malignant,"C649, All Other Sites","C64, See Topo Table B Col B",Not listed in ICD-O-3.2
8330/1/1,Atypical follicular adenoma (C739),Borderline,"C739, All Other Sites","D44.0, See Topo Table B Col F",
8330/2/1,Follicular adenocarcinoma in situ (C739),In-Situ,"C739, All Other Sites","D09.3, See Topo Table B Col D",Not listed in ICD-O-3.2
8330/3/1,"Follicular carcinoma, NOS (C739)",Malignant,"C739, All Other Sites","C73, See Topo Table B Col B",
8331/3/1,"Follicular adenocarcinoma, well differentiated (C739)",Malignant,"C739, All Other Sites","C73, See Topo Table B Col B",
8332/3/1,"Follicular adenocarcinoma, trabecular (C739)",Malignant,"C739, All Other Sites","C73, See Topo Table B Col B",
8333/3/1,Fetal adenocarcinoma,Malignant,Specific Sites,See Topo Table B Col B,
8335/1/1,"Follicular tumor of uncertain malignant potential (C739) (ICD-O-3.2 update, previously 8335/3)",Borderline,"C739, All Other Sites","D44.0, See Topo Table B Col F",New code 2021+
8335/2/1,Macrofollicular carcinoma in situ (C739),In-Situ,"C739, All Other Sites","D09.3, See Topo Table B Col D",Not listed in ICD-O-3.2
8335/3/1,"Follicular carcinoma, minimally invasive (C739) (ICD-O-3.2 update, see code 8335/1)",Malignant,"C739, All Other Sites","C73, See Topo Table B Col B",
8336/1/1,"Hyalinizing trabecular tumor (C739) (ICD-O-3.2 update, previously 8336/0)",Borderline,"C739, All Other Sites","D44.0, See Topo Table B Col F",
8337/3/1,Poor differentiated thyroid carcinoma (C739),Malignant,"C739, All Other Sites","C73, See Topo Table B Col B",
8339/3/1,"Follicular carcinoma, encapsulated, angioinvasive (C739) (ICD-O-3.2 update)",Malignant,"C739, All Other Sites","C73, See Topo Table B Col B",
8340/2/1,"Papillary carcinoma follicular variant, in situ follicular variant  (C739)",In-Situ,"C739, All Other Sites","D09.3, See Topo Table B Col D",Not listed in ICD-O-3.2
8340/3/1,"Papillary carcinoma, follicular variant (C739)",Malignant,"C739, All Other Sites","C73, See Topo Table B Col B",
8341/2/1,Papillary microcarcinoma in situ (C739),In-Situ,"C739, All Other Sites","D09.3, See Topo Table B Col D",Not listed in ICD-O-3.2
8341/3/1,Papillary microcarcinoma (C739),Malignant,"C739, All Other Sites","C73, See Topo Table B Col B",
8342/3/1,"Papillary carcinoma, oncocytic cell (C739)",Malignant,"C739, All Other Sites","C73, See Topo Table B Col B",
8343/2/1,"Papillary carcinoma, encapsulated, in situ (C739)",In-Situ,"C739, All Other Sites","D09.3, See Topo Table B Col D",Not listed in ICD-O-3.2
8343/3/1,"Papillary carcinoma, encapsulated of thyroid (C739)",Malignant,"C739, All Other Sites","C73, See Topo Table B Col B",
8344/2/1,"Papillary carcinoma, columnar cell, in situ (C739)",In-Situ,"C739, All Other Sites","D09.3, See Topo Table B Col D",Not listed in ICD-O-3.2
8344/3/1,"Papillary carcinoma, columnar cell (C739)",Malignant,"C739, All Other Sites","C73, See Topo Table B Col B",
8345/2/1,"Medullary carcinoma with amyloid stroma, in situ",In-Situ,Specific sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8345/3/1,Medcullary thyroid carcinoma (C739),Malignant,"C739, All Other Sites","C73, See Topo Table B Col B",
8346/3/1,Mixed medullary-follicular carcinoma (C739),Malignant,"C739, All Other Sites","C73, See Topo Table B Col B",
8347/3/1,Mixed medullary-papillary carcinoma  (C739),Malignant,"C739, All Other Sites","C73, See Topo Table B Col B",
8348/1/1,Well differentiated tumor of uncertain malignant potential (C739) (ICD-O-3.2 update),Borderline,"C739, All Other Sites","D44.0, See Topo Table B Col F",New code 2021+
8349/1/1,Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTYP) (C739) (ICD-O-3.2 update),Borderline,"C739, All Other Sites","D44.0, See Topo Table B Col F",New code 2021+
8350/3/1,Nonencapsulated sclerosing carcinoma (C739),Malignant,"C739, All Other Sites","C73, See Topo Table B Col B",
8360/1/1,Multiple endocrine adenomas,Borderline,Specific Sites,See Topo Table B Col F,
8360/3/1,"Multiple endocrine adenomas, malignant",Malignant,Specific Sites,See Topo Table B Col B,Not listed in ICD-O-3.2
8370/2/1,Adrenal cortical carcinoma in situ (C740),In-Situ,"C740, All Other Sites","D09.3, See Topo Table B Col D",Not listed in ICD-O-3.2
8370/3/1,Adrenal cortical carcinoma (C740),Malignant,"C740, All Other Sites","C74.0, See Topo Table B Col B",
8380/1/1,"Endometrioid adenoma, borderline malignancy (C541)",Borderline,"C541, All Other Sites","D39.0, See Topo Table B Col F",
8380/2/1,Endometrioid intraepithelial neoplasia (C541),In-Situ,"C541, All Other Sites","D07.0, See Topo Table C Col D",
8380/3/1,Endometrioid carcinoma (C541),Malignant,"C541, All Other Sites","C54.1, See Topo Table B Col B",
8381/1/1,"Endometrioid adenofibroma, borderline malignancy (C541)",Borderline,"C541, All Other Sites","D39.0, See Topo Table B Col F",
8381/2/1,Endometroid adenofibroma in situ (C541),In-Situ,"C541, All Other Sites","D07.0, See Topo Table C Col D",
8381/3/1,"Endometrioid adenofibroma, malignant (C541)",Malignant,"C541, All Other Sites","C54.1, See Topo Table B Col B",
8382/2/1,"Endometrioid adenocarcinoma in situ, secretory variant  (C541)",In-Situ,"C541, All Other Sites","D07.0, See Topo Table B Col D",Not listed in ICD-O-3.2
8382/3/1,"Endometrioid adenocarcinoma, secretory variant (C541)",Malignant,"C541, All Other Sites","C54.1, See Topo Table B Col B",
8383/3/1,"Endometrioid adenocarcinoma, ciliated cell variant (C541)",Malignant,"C541, All Other Sites","C54.1, See Topo Table B Col B",
8384/2/1,"Adenocarcinoma, endocervical type, in situ (C53_)",In-Situ,"C539, All Other Sites","D06.9, See Topo Table B Col D",Not listed in ICD-O-3.2
8384/3/1,"Adenocarcinoma, endocervical type (C53_)",Malignant,"C539, All Other Sites","C53.9, See Topo Table B Col B",
8390/2/1,Skin appendage carcinoma in situ (C44_),In-Situ,"C449, All Other Sites","D04.9, See Topo Table B Col D",Not listed in ICD-O-3.2
8390/3/1,"Adnexal adenocarcinoma, NOS (C44_)",Malignant,"C449, All Other Sites","C44.9, See Topo Table B Col B",
8392/3/1,Syringofibroadenocarcinoma (C44_),Malignant,"C449, All Other Sites","C44.9, See Topo Table B Col B",Not listed in ICD-O-3.2
8400/1/1,"Sweat gland tumor, NOS (C44_)",Borderline,"C449, All Other Sites","D48.5, See Topo Table B Col F",
8400/2/1,Sweat gland adenocarcinoma in situ (C44_),In-Situ,"C449, All Other Sites","D04.9, See Topo Table B Col D",Not listed in ICD-O-3.2
8400/3/1,Sweat gland adenocarcinoma (C44_),Malignant,"C449, All Other Sites","C44.9, See Topo Table B Col B",
8401/2/1,Apocrine adenocarcinoma in situ (C44_),In-Situ,"C449, All Other Sites","D04.9, See Topo Table B Col D",Not listed in ICD-O-3.2
8401/3/1,Apocrine adenocarcinoma (C44_),Malignant,"C449, All Other Sites","C44.9, See Topo Table B Col B",
8402/2/1,"Nodular hidradenoma, in situ (C44_)",In-Situ,"C449, All Other Sites","D04.9, See Topo Table B Col D",Not listed in ICD-O-3.2
8402/3/1,Hidradenocarcinoma (C44_),Malignant,"C449, All Other Sites","C44.9, See Topo Table B Col B",
8403/3/1,Malignant eccrine spiradenoma (C44_),Malignant,"C449, All Other Sites","C44.9, See Topo Table B Col B",
8405/3/1,Papillary hidradenocarcinoma,Malignant,Specific Sites,See Topo Table B Col B,Not listed in ICD-O-3.2
8406/3/1,Syringocystadenocarcinoma papilliferum (C44_),Malignant,"C449, All Other Sites","C44.9, See Topo Table B Col B",
8407/2/1,"Sclerosing sweat duct carcinoma, in situ",In-Situ,Specific sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8407/3/1,Microcystic adnexal carcinoma (C44_),Malignant,"C449, All Other Sites","C44.9, See Topo Table B Col B",
8408/1/1,"Aggressive digital papillary adenoma (C44_) (ICD-O-3.2 update, see code 8408/3)",Borderline,"C449, All Other Sites","D48.5, See Topo Table B Col F",
8408/2/1,Eccrine papillary adenocarcinoma (C44_),In-Situ,"C449, All Other Sites","D04.9, See Topo Table B Col D",Not listed in ICD-O-3.2
8408/3/1,"Digital papillary adenocarcinoma (C44_) ICD-O-3.2 update, previously 8408/1))",Malignant,"C449, All Other Sites","C44.9, See Topo Table B Col B",
8409/2/1,Porocarcinoma in situ (C44_),In-Situ,"C449, All Other Sites","D04.9, See Topo Table B Col D",
8409/3/1,"Porocarcinoma, NOS (C44_)",Malignant,"C449, All Other Sites","C44.9, See Topo Table B Col B",
8410/2/1,Sebaceous carcinoma in situ (C44_),In-Situ,"C449, All Other Sites","D04.9, See Topo Table B Col D",Not listed in ICD-O-3.2
8410/3/1,Sebaceous carcinoma (C44_),Malignant,"C449, All Other Sites","C44.9, See Topo Table B Col B",
8413/2/1,"Eccrine adenocarcinoma, in situ (C44_)",In-Situ,"C449, All Other Sites","D04.9, See Topo Table B Col D",Not listed in ICD-O-3.2
8413/3/1,Eccrine adenocarcinoma (C44_),Malignant,"C449, All Other Sites","C44.9, See Topo Table B Col B",
8420/3/1,Ceruminous adenocarcinoma (C442),Malignant,"C442, All Other Sites","C44.2, See Topo Table B Col B",
8430/1/1,Mucoepidermoid tumor [OBS],Borderline,Specific Sites,See Topo Table B Col F,
8430/2/1,Mucoepidermoid carcinoma in situ,In-Situ,Specific sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8430/3/1,Mucoepidermoid carcinoma,Malignant,Specific Sites,See Topo Table B Col B,
8440/2/1,Cystadenocarcinoma in situ,In-Situ,Specific sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8440/3/1,"Cystadenocarcinoma, NOS",Malignant,Specific Sites,See Topo Table B Col B,
8441/2/1,Serous intraepithelial carcinoma (C569),In-Situ,"C569, All Other Sites","D07.3, See Topo Table B Col D",
8441/3/1,"Serous carcinoma, NOS (C569)",Malignant,"C569, All Other Sites","C56, See Topo Table B Col B",
8442/1/1,"Serous borderline tumor, NOS (C569)  (ICD-O-3 update, previously 8463/1)",Borderline,"C569, All Other Sites","D39.1, See Topo Table B Col F",
8442/2/1,"Serous cystadenoma, in situ (C569)",In-Situ,"C569, All Other Sites","D07.3, See Topo Table B Col D",Not listed in ICD-O-3.2
8442/3/1,"Serous cystadenoma, malignant (C569) (ICD-O-3 update, 8463/3 moved to this code)",Malignant,"C569, All Other Sites","C56, See Topo Table B Col B",
8443/3/1,Clear cell cystadenocarcinoma (C569),Malignant,"C569, All Other Sites","C56, See Topo Table B Col B",Not listed in ICD-O-3.2
8444/1/1,"Clear cell cystic tumor of borderline malignancy (C569) (ICD-O-3.2 update, see code 8313/1)",Borderline,"C569, All Other Sites","D39.1, See Topo Table B Col F",
8444/3/1,"Clear cell cystic tumor, malignant",Malignant,Specific Sites,See Topo Table B Col B,Not listed in ICD-O-3.2
8450/3/1,"Papillary cystadenocarcinoma, NOS (C569)",Malignant,"C569, All Other Sites","C56, See Topo Table B Col B",
8451/1/1,"Papillary cystadenoma, borderline malignancy (C569)",Borderline,"C569, All Other Sites","D39.1, See Topo Table B Col F",
8452/1/1,Solid pseudopapillary tumor of ovary (C569) (ICD-O-3.2 update),Borderline,"C569, All Other Sites","D39.1, See Topo Table B Col F",
8452/2/1,"Solid pseudopapillary tumor, in situ (C25_)",In-Situ,"C259, All Other Sites","D01.7, See Topo Table B Col D",Not listed in ICD-O-3.2
8452/3/1,Solid pseudopapillary carcinoma of the pancreas (C25_),Malignant,"C259, All Other Sites","C25.9, See Topo Table B Col B",
8453/2/1,Intraductal Papillary mucinous neoplasm with high grade dysplasia (C25_),In-Situ,"C259, All Other Sites","D01.7, See Topo Table B Col D",
8453/3/1,Intraductal Papillary mucinous neoplasm with an associated invasive carcinoma (C25_),Malignant,"C259, All Other Sites","C25.9, See Topo Table B Col B",
8455/2/1,"Intraductal oncocytic papillary neoplasma, NOS (C25) (2022 update",In-Situ,"C259, All Other Sites","D01.7, See Topo Table B Col D",New code 2022+
8455/3/1,Intraductal oncocytic papillary neoplasm with associated invasive carcinoma (C25_) (2022 update),Malignant,"C259, All Other Sites","C25.9, See Topo Table B Col B",New code 2022+
8460/2/1,"Serous borderine tumor, micropapillary variant (C569)",In-Situ,"C569, All Other Sites","D07.3, See Topo Table B Col D",
8460/3/1,Low grade serous carcinoma (C569),Malignant,"C569, All Other Sites","C56, See Topo Table B Col B",
8461/2/1,"Serous surface papilloma, in situ (C569)",In-Situ,"C569, All Other Sites","D07.3, See Topo Table B Col D",Not listed in ICD-O-3.2
8461/3/1,Serous surface papillary carcinoma (C569),Malignant,"C569, All Other Sites","C56, See Topo Table B Col B",
8462/2/1,Serous papillary cystadenocarcinoma in situ (C569),In-Situ,"C569, All Other Sites","D07.3, See Topo Table B Col D",Not listed in ICD-O-3.2
8462/3/1,Papillary serous cystadenocarcinoma (C569),Malignant,"C569, All Other Sites","C56, See Topo Table B Col B",Not listed in ICD-O-3.2
8463/1/1,"Serous surface papillary tumor of borderline malignancy (C569) (ICD-O-3.2 update, see code 8442/1)",Borderline,"C569, All Other Sites","D39.1, See Topo Table B Col F",
8463/3/1,Serous surface papillary carcinoma (C569),Malignant,"C569, All Other Sites","C56, See Topo Table B Col B",Not listed in ICD-O-3.2
8470/2/1,"Mucinous cystic neoplams with high grade dysplasia (C25_) (ICD-O-3 update, now includes 8470/2)",In-Situ,"C259, All Other Sites","D01.7, See Topo Table B Col D",
8470/3/1,"Mucinous cystadenocarcinoma, NOS (C569) (ICD-O-3 update, now includes 8471/3)",Malignant,"C569, All Other Sites","C56, See Topo Table B Col B",
8471/2/1,"Papillary mucinous cystadenoca situ, NOS (C569) (ICD-O-3.2 update, see code 8470/2)",In-Situ,"C569, All Other Sites","D07.3, See Topo Table B Col D",
8471/3/1,"Papillary mucinous cystadenocarcinoma (C569) (ICD-O-3.2 update, see code 8470/3)",Malignant,"C569, All Other Sites","C56, See Topo Table B Col B",
8472/1/1,"Mucinous cystic tumor of borderline malignancy (C569) (ICD-O-3 update, 8473/1 moved to this code)",Borderline,"C569, All Other Sites","D39.1, See Topo Table B Col F",
8472/2/1,"Mucinous cystic adenocarcinoma in situ (C569) (ICD-O-update, 8473/2 moved to this code)",In-Situ,"C569, All Other Sites","D07.3, See Topo Table B Col D",
8472/3/1,"Mucinous cystadenocarcinoma  (C569) (ICD-O-3 update, 8473/3 moved to this code)",Malignant,"C569, All Other Sites","C56, See Topo Table B Col B",
8473/1/1,"Papillary mucinous cystadenoma, borderline malignancy (C569) (ICD-O-3.2 update, see code 8472/1)",Borderline,"C569, All Other Sites","D39.1, See Topo Table B Col F",
8473/2/1,"Papillary mucinous cystadenoma, in situ (C569) (ICD-O-3.2 update, see code 8472/2)",In-Situ,"C569, All Other Sites","D07.3, See Topo Table B Col D",Not listed in ICD-O-3.2
8473/3/1,"Papillary pseudomucinous cystadenocarcinoma (ICD-O-3.2 update, see code 8472/3)",Malignant,"C569, All Other Sites","C56, See Topo Table B Col B",Not listed in ICD-O-3.2
8474/1/1,Seromucinous borderline tumor (ICD-O-3.2 update) (C569),Borderline,"C569, All Other Sites","D39.1, See Topo Table B Col F",New code 2021+
8474/2/1,"Seromucinous carcinoma, in situ",In-Situ,Specific Sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8474/3/1,Seromucinous carcinoma (ICD-O-3.2 update) (C569),Malignant,"C569, All Other Sites","C56, See Topo Table B Col B",New code 2021+
8480/1/1,Low grade appendiceal mucinous neoplasm (C181),Borderline,"C181, All Other Sites","D37.3, See Topo Table B, Col F",
8480/2/1,Mucinous adenocarcinoma in situ,In-Situ,Specific Sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8480/3/1,Mucinous adenocarcinoma,Malignant,Specific Sites,See Topo Table B Col B,
8480/6/1,Pseudomyxoma peritonei (C809),Metastatic,Specific Sites,See Topo Table B Col C,Not a code used in the registry
8481/2/1,Mucin-producing adenocarcinoma in situ,In-Situ,Specific Sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8481/3/1,Mucin-producing adenocarcinoma,Malignant,Specific Sites,See Topo Table B Col B,
8482/3/1,"Mucinous adenocarcinoma, gastric type",Malignant,Specific Sites,See Topo Table B Col B,
8483/2/1,"Adenocarcinoma in situ, HPV associated (C53_) (2022 update)",In-Situ,"C539, All Other Sites","D06.9, See Topo Table B Col D",New code 2022+
8483/3/1,Adenocarcinoma-HPV associated (C53_) (2022 update),Malignant,"C539, All Other Sites","C53.9, See Topo Table B Col B",New code 2022+
8484/2/1,"Adenocarcinoma in situ, HPV independent, NOS (C53_) (2022 update)",In-Situ,"C539, All Other Sites","D06.9, See Topo Table B Col D",New code 2022+
8484/3/1,"Adenocarcinoma, HPV-independent (C53_) (2022 update)",Malignant,"C539, All Other Sites","C53.9, See Topo Table B Col B",New code 2022+
8490/2/1,Signet ring cell carcinoma in situ,In-Situ,Specific Sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8490/3/1,Signet ring cell carcinoma,Malignant,Specific Sites,See Topo Table B Col B,
8490/6/1,Metastatic signet ring cell carcinoma,Metastatic,Specific Sites,See Topo Table B Col C,Not a code used in the registry
8500/2/1,"Intraductal carcinoma, noninfiltrating, NOS (C50_)",In-Situ,"C509, All Other Sites","D05.0, See Topo Table B Col D",
8500/3/1,"Infiltrating duct carcinoma, NOS (C50_)",Malignant,"C509, All Other Sites","C50.9, See Topo Table B Col B",
8501/2/1,"Comedocarcinoma, noninfiltrating  (C50_)",In-Situ,"C509, All Other Sites","D05.8, See Topo Table B Col D",
8501/3/1,"Comedocarcinoma, NOS (C50_)",Malignant,"C509, All Other Sites","C50.9, See Topo Table B Col B",
8502/2/1,"Secretory carcinoma of breast, in situ (C50_)",In-Situ,"C509, All Other Sites","D05.8, See Topo Table B Col D",Not listed in ICD-O-3.2
8502/3/1,Secretory carcinoma of breast (C50_),Malignant,"C509, All Other Sites","C50.9, See Topo Table B Col B",
8503/2/1,Noninfiltrating intraductal papillary adenocarcinoma (C50_),In-Situ,"C509, All Other Sites","D05.8, See Topo Table B Col D",
8503/3/1,Intraductal papillary adenocarcinoma with invasion (C50_),Malignant,"C509, All Other Sites","C50.9, See Topo Table B Col B",
8504/2/1,Intracystic carcinoma (ICD-O-3.2 update),In-Situ,Specific Sites,See Topo Table B Col D,
8504/3/1,"Intracystic carcinoma, NOS (ICD-O-3.2 update, see code 8504/2)",Malignant,Specific Sites,See Topo Table B Col B,
8507/2/1,Intraductal micropapillary carcinoma (C50_),In-Situ,"C509, All Other Sites","D05.8, See Topo Table B Col D",
8507/3/1,Invasive micropapillary carcinoma of breast (C50_),Malignant,"C509, All Other Sites","C50.9, See Topo Table B Col B",
8508/2/1,"Cystic hypersecretory carcinoma, in situ (C50_)",In-Situ,"C509, All Other Sites","D05.8, See Topo Table B Col D",Not listed in ICD-O-3.2
8508/3/1,Cystic hypersecretory carcinoma (C50_),Malignant,"C509, All Other Sites","C50.9, See Topo Table B Col B",
8509/2/1,Solid papillary carcinoma in situ (C50_) (ICD-O-3.2 update),In-Situ,"C509, All Other Sites","D05.8, See Topo Table B Col D",
8509/3/1,Solid papillary carcinoma with invasion (C50_) (ICD-O-3.2 update),Malignant,"C509, All Other Sites","C50.9, See Topo Table B Col B",
8510/2/1,Medullary carcinoma in situ (C739),In-Situ,"C739, All Other Sites","D09.3, See Topo Table B Col D",Not listed in ICD-O-3.2
8510/3/1,"Medullary carcinoma, NOS (C739)",Malignant,"C739, All Other Sites","C73, See Topo Table B Col B",
8512/3/1,Medullary carcinoma with lymphoid stroma (C50_),Malignant,"C509, All Other Sites","C50.9, See Topo Table B Col B",
8513/3/1,Atypical medullary carcinoma (C50_),Malignant,"C509, All Other Sites","C50.9, See Topo Table B Col B",
8514/3/1,"Duct carcinoma, desmoplastic type (C50_)",Malignant,"C509, All Other Sites","C50.9, See Topo Table B Col B",
8519/2/1,"Lobular carcinoma in situ, pleomorphic (C50_) ICD-O-3.2 update)",In-Situ,"C509, All Other Sites","D05.0, See Topo Table B Col D",New code 2021+
8520/2/1,Lobular carcinoma in situ (C50_),In-Situ,"C509, All Other Sites","D05.0, See Topo Table B Col D",
8520/3/1,"Lobular carcinoma, NOS (C50_)",Malignant,"C509, All Other Sites","C50.9, See Topo Table B Col B",
8521/2/1,Ductular carcinoma in situ (C50_),In-Situ,"C509, All Other Sites","D05.0, See Topo Table B Col D",Not listed in ICD-O-3.2
8521/3/1,Infiltrating ductular carcinoma (C50_),Malignant,"C509, All Other Sites","C50.9, See Topo Table B Col B",
8522/2/1,Intraductal and lobular in situ carcinoma (C50_),In-Situ,"C509, All Other Sites","D05.8, See Topo Table B Col D",
8522/3/1,Infiltrating duct and lobular carcinoma (C50_),Malignant,"C509, All Other Sites","C50.9, See Topo Table B Col B",
8523/2/1,Intraductal with other types of carcinoma in situ (C50_),In-Situ,"C509, All Other Sites","D05.8, See Topo Table B Col D",Not listed in ICD-O-3.2
8523/3/1,Infiltrating duct mixed with other types of carcinoma (C50_),Malignant,"C509, All Other Sites","C50.9, See Topo Table B Col B",
8524/2/1,"Infiltrating lobular mixed with other types of carcinoma, in situ (C50_)",In-Situ,"C509, All Other Sites","D05.8, See Topo Table B Col D",Not listed in ICD-O-3.2
8524/3/1,Infiltrating lobular mixed with other types of carcinoma (C50_),Malignant,"C509, All Other Sites","C50.9, See Topo Table B Col B",
8525/2/1,"Polymorphous low grade adenocarcinoma, in situ",In-Situ,Specific sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8525/3/1,Polymorphous adenocarcinoma,Malignant,Specific Sites,See Topo Table B Col B,
8530/3/1,Inflammatory carcinoma (C50_),Malignant,"C509, All Other Sites","C50.9, See Topo Table B Col B",
8540/2/1,"Paget disease, mammary in situ (C50_)",In-Situ,"C509, All Other Sites","D05.8, See Topo Table B Col D",Not listed in ICD-O-3.2
8540/3/1,"Paget disease, mammary (C50_)",Malignant,"C509, All Other Sites","C50.9, See Topo Table B Col B",
8541/2/1,Paget disease in situ and ductal carcinoma (C50_),In-Situ,"C509, All Other Sites",,Not listed in ICD-O-3.2
8541/3/1,Paget disease and infiltrating ductal carcinoma of breast (C50_),Malignant,"C509, All Other Sites","C50.9, See Topo Table B Col B",
8542/2/1,"Paget disease (in situ), extramammary (except Paget disease of bone) (C50_)",In-Situ,"C509, All Other Sites","D05.8, See Topo Table B Col D",Not listed in ICD-O-3.2
8542/3/1,"Paget disease, extramammary (C25_)",Malignant,"C259, All Other Sites","C25.9, All Other Sites",
8543/2/1,Paget disease in situ and intraductal carcinoma (C50_),In-Situ,"C509, All Other Sites","D05.8, See Topo Table B Col D",Not listed in ICD-O-3.2
8543/3/1,Paget disease and intraductal carcinoma of the breast  (C50_),Malignant,"C509, All Other Sites","C50.9, See Topo Table B Col B",
8550/1/1,Acinar cell tumor,Borderline,Specific Sites,See Topo Table B Col F,
8550/2/1,Acinar cell carcinoma in situ,In-Situ,Specific Sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8550/3/1,Acinar cell carcinoma,Malignant,Specific Sites,See Topo Table B Col B,
8551/3/1,Acinar cell cystadenocarcinoma,Malignant,Specific Sites,See Topo Table B Col B,
8552/3/1,Mixed acinar-ductal carcinoma,Malignant,Specific Sites,See Topo Table B Col B,
8560/2/1,Squamous cell carcinoma in situ and glandular papilloma,In-Situ,Specific Sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8560/3/1,Adenosquamous carcinoma,Malignant,Specific Sites,See Topo Table B Col B,
8561/3/1,"Warthin tumor, malignant (C07_, C08_)",Malignant,"C079, C089, All Other Sites","C07, C08.9, See Topo Table B Col B",Not listed in ICD-O-3.2
8562/2/1,Epithelial-myoepithelial carcinoma in situ,In-Situ,Specific Sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8562/3/1,Epithelial-myoepithelial carcinoma,Malignant,Specific Sites,See Topo Table B Col B,
8570/2/1,Adenocarcinoma in situ with squamous metaplasia,In-Situ,Specific Sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8570/3/1,Adenocarcinoma with squamous metaplasia,Malignant,Specific Sites,See Topo Table B Col B,
8571/3/1,Adenocarcinoma with cartilaginous and osseous metaplasia,Malignant,Specific Sites,See Topo Table B Col B,
8572/3/1,Adenocarcinoma with spindle cell metaplasia,Malignant,Specific Sites,See Topo Table B Col B,
8573/2/1,Adenocarcinoma in situ with apocrine metaplasia,In-Situ,Specific Sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8573/3/1,Adenocarcinoma with apocrine metaplasia,Malignant,Specific Sites,See Topo Table B Col B,
8574/2/1,Adenocarcinoma in situ with neuroendocrine differentiation,In-Situ,Specific Sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8574/3/1,Adenocarcinoma with neuroendocrine differentiation,Malignant,Specific Sites,See Topo Table B Col B,
8575/3/1,"Metaplastic carcinoma, NOS",Malignant,Specific Sites,See Topo Table B Col B,
8576/3/1,Hepatoid adenocarcinoma,Malignant,Specific Sites,See Topo Table B Col B,
8580/1/1,"Thymoma, NOS (C379) (ICD-O-3.2 update, see code 8580/3)",Borderline,"C379, All Other Sites","D38.4, See Topo Table B Col F",
8580/2/1,"Thymoma, in situ, NOS (C379)",In-Situ,"C379, All Other Sites","D09.3, See Topo Table B Col D",
8580/3/1,"Thymoma, NOS (C379)  (ICD-O-3.2 update, previously 8580/1)",Malignant,"C379, All Other Sites","C37, See Topo Table B Col B",
8581/1/1,"Thymoma, type A, NOS (C379) (ICD-O-3.2 update, see code 8581/3)",Borderline,"C379, All Other Sites","D38.4, See Topo Table B Col F",
8581/3/1,"Thymoma, type A (C379) (ICD-O-3.2 update, previously 8581/1)",Malignant,"C379, All Other Sites","C37, See Topo Table B Col B",
8582/1/1,"Thymoma, type AB, NOS (C379) (ICD-O-3.2 update, see code 8582/3)",Borderline,"C379, All Other Sites","D38.4, See Topo Table B Col F",
8582/3/1,"Thymoma, type AB (C379) (ICD-O-3.2 update, previously 8582/1)",Malignant,"C379, All Other Sites","C37, See Topo Table B Col B",
8583/1/1,"Thymoma, type B1, NOS (C379) (ICD-O-3.2 update, see code 8583/3)",Borderline,"C379, All Other Sites","D38.4, See Topo Table B Col F",
8583/3/1,"Thymoma, type B1 (C379) (ICD-O-3.2 update, previously 8585/1)",Malignant,"C379, All Other Sites","C37, See Topo Table B Col B",
8584/1/1,"Thymoma, type B2, NOS (C379) (ICD-O-3.2 update, see code 8584/3)",Borderline,"C379, All Other Sites","D38.4, See Topo Table B Col F",
8584/3/1,"Thymoma, type B2 (C379) (ICD-O-3.2 update, previously 8584/1)",Malignant,"C379, All Other Sites","C37, See Topo Table B Col B",
8585/1/1,"Thymoma, type B3, NOS (C379) (ICD-O-3.2 update, see code 8585/3)",Borderline,"C379, All Other Sites","D38.4, See Topo Table B Col F",
8585/3/1,"Thymoma, type B3 (C379) (ICD-O-3.2, previously 8585/1)",Malignant,"C379, All Other Sites","C37, See Topo Table B Col B",
8586/3/1,"Thymic carcinoma, NOS (C379)",Malignant,"C379, All Other Sites","C37, See Topo Table B Col B",
8588/3/1,Spindle epithelial tumor with thymus-like element (C379),Malignant,"C379, All Other Sites","C37, See Topo Table B Col B",
8589/3/1,Intrathyroid thymic carcinoma (C379),Malignant,"C379, All Other Sites","C37, See Topo Table B Col B",
8590/1/1,"Sex cord-gonadal stromal tumor, NOS (C569 [F], C62_[M])",Borderline,"C569 [F], C629 [M], All Other Sites","D39.1 [F], D40.1 [M], See Topo Table B Col F",
8590/3/1,"Sex cord-gonadal stromal tumor, malignant, NOS (C569 [F], C62_[M])",Malignant,"C569 [F], C629 [M], All Other Sites","C56 [F], C62.9 [M], See Topo Table B Col B",Not listed in ICD-O-3.2
8591/1/1,"Sex cord-gonadal stromal tumor, incompletely differentiated (C569 [F], C62_[M])",Borderline,"C569 [F], C629 [M], All Other Sites","D39.1 [F], D40.1 [M], See Topo Table B Col F",
8591/1/1,"Sex cord-gonadal stromal tumor, incompletely differentiated",Borderline,"C569, All Other Sites","D39.1, See Topo Table B Col F",
8592/1/1,"Sex cord-gonadal stromal tumor, mixed forms (C569 [F], C62_[M])",Borderline,"C569 [F], C629 [M], All Other Sites","D39.1 [F], D40.1 [M], See Topo Table B Col F",
8593/1/1,Stromal tumor with minor sex cord elements (C569),Borderline,"C569, All Other Sites","D39.1, See Topo Table B Col F",
8593/3/1,"Malignant stromal tumor, with sex cord elements (C569)",Malignant,"C569, All Other Sites","C56, See Topo Table B Col B",Not listed in ICD-O-3.2
8594/1/1,"Mixed germal cell-sex cord-stromal tumor, NOS (ICD-O-3.2 update) (C569 [F], C62_[M])",Borderline,"C569, All Other Sites","D39.1, See Topo Table B Col F",
8600/3/1,"Thecoma, malignant  (C569)",Malignant,"C569, All Other Sites","C56, See Topo Table B Col B",
8602/3/1,"Sclerosing stromal tumor, malignant  (C569)",Malignant,"C569, All Other Sites","C56, See Topo Table B Col B",
8620/1/1,"Adult granulosa cell tumor of testis (C62-) (ICD-O-3.2 update, see 8620/3)",Borderline,"C569, All Other Sites","D39.1, See Topo Table B Col F",
8620/3/1,"Adult granulosa tumor of ovary (C569) (ICD-O-3.2 update, previously 8620/1)",Malignant,"C569, All Other Sites","C56, See Topo Table B Col B",
8621/1/1,Granulosa cell-theca cell tumor  (C569),Borderline,"C569, All Other Sites","D39.1, See Topo Table B Col F",
8621/3/1,"Granulosa cell-theca cell tumor, malignant  (C569)",Malignant,"C569, All Other Sites","C56, See Topo Table B Col B",Not listed in ICD-O-3.2
8622/1/1,"Granulosa cell tumor,  juvenile (C569)",Borderline,"C569, All Other Sites","D39.1, See Topo Table B Col F",
8622/3/1,"Juvenile granulosa cell tumor, malignant  (C569)",Malignant,"C569, All Other Sites","C56, See Topo Table B Col B",Not listed in ICD-O-3.2
8623/1/1,Sex cord tumor with annular tubules (C569),Borderline,"C569, All Other Sites","D39.1, See Topo Table B Col F",
8623/3/1,"Sex cord tumor with annular tubules, malignant  (C569)",Malignant,"C569, All Other Sites","C56, See Topo Table B Col B",Not listed in ICD-O-3.2
8630/1/1,"Androblastoma, NOS (C569 [F], C62_[M])",Borderline,"C569 [F], C629 [M], All Other Sites","D39.1 [F], D40.1 [M], See Topo Table B Col F",
8630/3/1,"Androblastoma, malignant (C569 [F], C62_[M])",Malignant,"C569 [F], C629 [M], All Other Sites","C56 [F], C62.9 [M], See Topo Table B Col B",
8631/1/1,"Sertoli-Leydig cell tumor of intermediate differentiation (C569 [F], C62_[M])",Borderline,"C569 [F], C629 [M], All Other Sites","D39.1 [F], D40.1 [M], See Topo Table B Col F",
8631/3/1,"Sertoli-Leydig cell tumor, poorly differentiated (C569 [F], C62_[M])",Malignant,"C569 [F], C629 [M], All Other Sites","C56 [F], C62.9 [M], See Topo Table B Col B",
8632/1/1,Gynandroblastoma (C569 ),Borderline,"C569, All Other Sites","D39.1, See Topo Table B Col F",
8632/3/1,"Gynandroblastoma, malignant (C569 )",Malignant,"C569, All Other Sites","C56, See Topo Table B Col B",Not listed in ICD-O-3.2
8633/1/1,"Sertoli-Leydig cell tumor, retiform (C569 [F], C62_[M])",Borderline,"C569 [F], C629 [M], All Other Sites","D39.1 [F], D40.1 [M], See Topo Table B Col F",
8633/3/1,"Sertoli-Leydig cell tumor, retiform, malignant (C569 [F], C62_[M])",Malignant,"C569 [F], C629 [M], All Other Sites","C56 [F], C62.9 [M], See Topo Table B Col B",Not listed in ICD-O-3.2
8634/1/1,"Sertoli-Leydig cell tumor, intermediate differentiation, with heterologous elements (C569 [F], C62_[M])",Borderline,"C569 [F], C629 [M], All Other Sites","D39.1 [F], D40.1 [M], See Topo Table B Col F",
8634/3/1,"Sertoli-Leydig cell tumor, poorly differentiated with heterologous elements (C569 [F], C62_[M])",Malignant,"C569 [F], C629 [M], All Other Sites","C56 [F], C62.9 [M], See Topo Table B Col B",
8640/1/1,"Sertoli cell tumor, NOS (C569 [F], C62_[M])",Borderline,"C569 [F], C619 [M], All Other Sites","D39.1 [F], D40.0 [M], See Topo Table B Col F",
8640/3/1,"Sertoli cell carcinoma  (C569 [F], C62_[M])",Malignant,"C569 [F], C629 [M], All Other Sites","C56 [F], C62.9 [M], See Topo Table B Col B",
8642/1/1,"Large cell calcifying Sertoli cell tumor  (C569 [F], C62_[M])",Borderline,"C569 [F], C619 [M], All Other Sites","D39.1 [F], D40.0 [M], See Topo Table B Col F",
8642/3/1,"Large cell calcifying Sertoli cell tumor, malignant  (C569 [F], C62_[M])",Malignant,"C569 [F], C629 [M], All Other Sites","C56 [F], C62.9 [M], See Topo Table B Col B",Not listed in ICD-O-3.2
8643/1/1,Intratulbar large cell hyalinizing Sertoli cell neoplasia (ICD-O-3.2 update),Borderline,Specific Sites,See Topo Table B Col F,New code 2021+
8650/1/1,"Leydig cell tumor of testis, NOS (C629) (ICD-O-3.2 update)",Borderline,"C629, All Other Sites","D40.0, See Topo Table B Col F",
8650/3/1,"Leydig cell tumor, malignant (C62_)",Malignant,"C629, All Other Sites","C62.9, See Topo Table B Col B",
8670/3/1,"Steroid cell tumor, malignant (C569)",Malignant,"C569, All Other Sites","C56, See Topo Table B Col B",
8680/1/1,"Paraganglioma, NOS (C755) (ICD-O-3.2 update, see code 8680/3) (C755)",Borderline,"C755, All Other Sites","D44.7, See Topo Table B Col F",
8680/3/1,"Paraganglioma, NOS (C755) (ICD-O-3.2 update, previously 8680/0, 8680/1)",Malignant,"C755, All Other Sites","C75.5, See Topo Table B Col B",
8681/1/1,"Sympathetic paraganglioma (C755) (ICD-O-3.2 update, see code 8681/3)",Borderline,"C755, All Other Sites","D44.7, See Topo Table B Col F",
8681/3/1,"Sympathetic paraganglioma (C755) (ICD-O-3.2 update, previously 8681/1)",Malignant,"C755, All Other Sites","C75.5, See Topo Table B Col B",
8682/1/1,"Parasympathetic paraganglioma (C755) (ICD-O-3.2 update, see code 8682/3)",Borderline,"C755, All Other Sites","D44.7, See Topo Table B Col F",
8682/3/1,"Parasympathetic paraganglioma (C755) (ICD-O-3.2 update, previously 8682/1)",Malignant,"C755, All Other Sites","C75.5, See Topo Table B Col B",
8683/3/1,"Gangliocytic paraganglioma, malignant (C170)",Malignant,"C170, All Other Sites",See Topo Table B Col B,Not listed in ICD-O-3.2
8690/1/1,"Glomus jugulare tumor, NOS (C755) (ICD-O-3.2 update, see code 8690/3)",Borderline,"C755, All Other Sites","D44.7, See Topo Table B Col F",
8690/3/1,"Middle ear paraganglioma (C755) (ICD-O-3.2 update, previously 8690/1)",Malignant,"C755, All Other Sites","C75.5, See Topo Table B Col B",
8691/1/1,"Aortic body tumor (C755) (ICD-O-3.2 update, see code 8691/3)",Borderline,"C755, All Other Sites","D44.7, See Topo Table B Col F",
8691/3/1,"Aortic body tumor (C755) ICD-O-3.2 update, previously 8691/1)",Malignant,"C755, All Other Sites","C75.5, See Topo Table B Col B",
8692/1/1,"Carotid body tumor (C754) (ICD-O-3.2 update, see code 8692/3)",Borderline,"C754, All Other Sites","D44.6, See Topo Table B Col F",
8692/3/1,"Carotid body paraganglioma (C754) (ICD-O-3.2 update, previously 8692/1)",Malignant,"C754, All Other Sites","C75.4, See Topo Table B Col B",
8693/1/1,"Extra-adrenal paraganglioma, NOS (C755) (ICD-O-3.2 update, see code 8693/3)",Borderline,"C755, All Other Sites","D44.7, See Topo Table B Col F",
8693/3/1,"Extra-adrenal paraganglioma, NOS (C755) (ICD-O-3.2 update, previously 8693/1)",Malignant,"C755, All Other Sites","C75.5, See Topo Table B Col B",
8700/3/1,"Pheochromocytoma, NOS (C741) (ICD-O-3.2 update, previously 8700/0)",Malignant,"C741, All Other Sites","C74.1, See Topo Table B Col B",
8710/3/1,Glomangiosarcoma (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8711/1/1,Glomangiomatosis (ICD-O-3.2 update),Borderline,Specific Sites,See Topo Table B Col F,
8711/3/1,"Glomus tumor, malignant (C49_)",Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8712/3/1,"Glomangioma, malignant",Malignant,Specific Sites,See Topo Table B Col B,Not listed in ICD-O-3.2
8713/3/1,"Glomangiomyoma, malignant",Malignant,Specific Sites,See Topo Table B Col B,Not listed in ICD-O-3.2
8714/3/1,"Perivascular, epithelioid tumor, malignant (ICD-O-3.2 update)",Malignant,Specific Sites,See Topo Table B Col B,
8720/2/1,Melanoma in situ (C44_),In-Situ,"C449, All Other Sites","D03.9, See Topo Table B Col I",
8720/3/1,"Malignant melanoma, NOS (C44_)",Malignant,"C449, All Other Sites","C43.9, See Topo Table B Col H",
8721/2/1,"Nodular melanoma, in situ (C44_)",In-Situ,"C449, All Other Sites","D03.9, See Topo Table B Col I",Not listed in ICD-O-3.2
8721/3/1,Nodular melanoma (C44_),Malignant,"C449, All Other Sites","C43.9, See Topo Table B Col H",
8722/2/1,"Balloon cell melanoma, in situ (C44_)",In-Situ,"C449, All Other Sites","D03.9, See Topo Table B Col I",Not listed in ICD-O-3.2
8722/3/1,Balloon cell melanoma (C44_),Malignant,"C449, All Other Sites","C43.9, See Topo Table B Col H",
8723/2/1,"Melanoma in situ, regressing (C44_)",In-Situ,"C449, All Other Sites","D03.9, See Topo Table B Col I",Not listed in ICD-O-3.2
8723/3/1,"Malignant melanoma, regressing (C44_)",Malignant,"C449, All Other Sites","C43.9, See Topo Table B Col H",
8726/3/1,Malignant melanoma in magnocellular nevus (C694),Malignant,"C694, All Other Sites","C69.4, See Topo Table B Col B",Not listed in ICD-O-3.2
8727/3/1,"Dysplastic nevus, malignant (C44_)",Malignant,"C449, All Other Sites","C43.9, See Topo Table B Col H",Not listed in ICD-O-3.2
8728/1/1,Meningeal melanocytoma (C70_),Borderline,"C709, All Other Sites","D42.9, See Topo Table B Col F",
8728/3/1,Meningeal melanomastosis (C70_),Malignant,"C709, All Other Sites","C70.9, See Topo Table B Col B",
8730/2/1,Melanoma in situ in junctional nevus (C44_),In-Situ,,"D03.9, See Topo Table B Col I",Not listed in ICD-O-3.2
8730/3/1,Amelanotic melanoma (C44_),Malignant,"C449, All Other Sites","C43.9, See Topo Table B Col H",
8740/2/1,Melanoma in situ in junctional nevus (C44_),In-Situ,"C449, All Other Sites","D03.9, See Topo Table B Col I",Not listed in ICD-O-3.2
8740/3/1,Malignant melanoma in junctional nevus (C44_),Malignant,"C449, All Other Sites","C43.9, See Topo Table B Col H",
8741/2/1,"Precancerous melanosis, NOS (C44_)",In-Situ,"C449, All Other Sites","D03.9, See Topo Table B Col I",
8741/3/1,Malignant melanoma in precancerous melanosis (C44_),Malignant,"C449, All Other Sites","C43.9, See Topo Table B Col H",
8742/2/1,Lentigo maligna (C44_),In-Situ,"C449, All Other Sites","D03.9, See Topo Table B Col I",
8742/3/1,Lentigo maligna melanoma (C44_),Malignant,"C449, All Other Sites","C43.9, See Topo Table B Col H",
8743/2/1,"Low cumulative sun damage melanoma, in situ (C44_)",In-Situ,"C449, All Other Sites","D03.9, See Topo Table B Col I",Not listed in ICD-O-3.2
8743/3/1,Low cumulative sun damage melanoma (C44_),Malignant,"C449, All Other Sites","C43.9, See Topo Table B Col H",
8744/2/1,"Acral lentiginous melanoma, in situ (C44_)",In-Situ,"C449, All Other Sites","D03.9, See Topo Table B Col I",Not listed in ICD-O-3.2
8744/3/1,"Acral lentiginous melanoma, in malignant (C44_)",Malignant,"C449, All Other Sites","C43.9, See Topo Table B Col H",
8745/2/1,"Desmoplastic melanoma, in situ (C44_)",In-Situ,"C449, All Other Sites","D03.9, See Topo Table B Col I",Not listed in ICD-O-3.2
8745/3/1,"Desmoplastic melanoma, malignant (C44_)",Malignant,"C449, All Other Sites","C43.9, See Topo Table B Col H",
8746/2/1,Mucosal lentiginous melanoma in situ,In-Situ,Specific Sites,See Topo Table B Col D,Not listed in ICD-O-3.2
8746/3/1,Mucosal lentiginous melanoma,Malignant,Specific Sites,See Topo Table B Col B,
8760/2/1,Melanoma in situ in compound nevus (C44_),In-Situ,"C449, All Other Sites","D03.9, See Topo Table B Col I",Not listed in ICD-O-3.2
8761/1/1,"Giant pigmented nevus, NOS (C44_)",Borderline,"C449, All Other Sites","D48.5, See Topo Table B Col F",
8761/2/1,Melanoma in situ in giant pigmented nevus (C44_),In-Situ,"C449, All Other Sites","D03.9, See Topo Table B Col I",Not listed in ICD-O-3.2
8761/3/1,Malignant melanoma in giant congenital nevus (C44_),Malignant,"C449, All Other Sites","C43.9, See Topo Table B Col H",
8762/1/1,Proliferative dermal lesion in congenital nevus (C44_),Borderline,"C449, All Other Sites","D48.5, See Topo Table B Col F",
8770/2/1,Epithelioid and spindle cell melanoma in situ (C44_),In-Situ,"C449, All Other Sites","D03.9, See Topo Table B Col I",Not listed in ICD-O-3.2
8770/3/1,Malignant Spitz tumor (C44_),Malignant,"C449, All Other Sites","C43.9, See Topo Table B Col H",
8771/2/1,Epithelioid cell melanoma in situ (C44_),In-Situ,"C449, All Other Sites","D03.9, See Topo Table B Col I",Not listed in ICD-O-3.2
8771/3/1,Epithelioid cell melanoma (C44_),Malignant,"C449, All Other Sites","C43.9, See Topo Table B Col H",
8772/2/1,"Spindle cell melanoma in situ, NOS (C44_)",In-Situ,"C449, All Other Sites","D03.9, See Topo Table B Col I",Not listed in ICD-O-3.2
8772/3/1,"Spindle cell melanoma, NOS  (C44_)",Malignant,"C449, All Other Sites","C43.9, See Topo Table B Col H",
8773/3/1,"Spindle cell melanoma, type A (C69_)",Malignant,"C699, All Other Sites","C69.9, See Topo Table B Col B",
8774/3/1,"Spindle cell melanoma, type B (C69_)",Malignant,"C699, All Other Sites","C69.9, See Topo Table B Col B",
8780/1/1,Pigmented epithelioid melanocytoma (C44_) (ICD-O-3.2 update),Borderline,"C449, All Other Sites","D48.5, See Topo Table B Col F",New code 2021+
8780/3/1,"Blue nevus, malignant (C44_)",Malignant,"C449, All Other Sites","C43.9, See Topo Table B Col H",
8790/3/1,"Cellular blue nevus, malignant (C44_)",Malignant,"C449, All Other Sites","C43.9, See Topo Table B Col H",
8800/3/1,"Sarcoma, NOS  (C49_)",Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8800/9/1,Sarcomatosis (C809),Unknown,C809,C80,Not a code used in the registry
8801/3/1,Spindle cell sarcoma  (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8802/1/1,Pleomorphic hyalinizing angiectatic tumor (C49_) (ICD-O-3.2 update),Borderline,"C499, All Other Sites","D48.1, See Topo Table B Col F",New code 2021+
8802/3/1,Giant cell sarcoma  (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8803/3/1,Small cell sarcoma  (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8804/3/1,Epithelioid sarcoma  (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8805/3/1,Undifferentiated sarcoma (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8806/3/1,Desmoplastic small round cell tumor  (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8810/1/1,Cellular fibroma (C569),Borderline,"C569, All Other Sites","D39.1, See Topo Table B Col F",
8810/3/1,"Fibrosarcoma, NOS (C49_)",Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8811/1/1,Myxoinflammatory fibroblastic sarcoma (C49_) (ICD-O-3.2 update),Borderline,"C499, All Other Sites","D48.1, See Topo Table B Col F",
8811/3/1,Myxofibrosarcoma (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8812/3/1,"Periosteal fibrosarcoma (C40_,C41_)",Malignant,"C409, C419, All Other Sites","C40.9, C41.9, See Topo Table B Col B",
8813/1/1,Palmar/plantar type fibromatosis (C49_) (ICD-O-3.2 update),Borderline,"C499, All Other Sites","D48.1, See Topo Table B Col F",
8813/3/1,Fascial fibrosarcoma (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8814/3/1,Infantile fibrosarcoma (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8815/1/1,"Solitary fibrous tumor, NOS (C49_) (ICD-O-3.2 update, previously 8815/0, 9150/0, 9150/1)",Borderline,"C499, All Other Sites","D48.1, See Topo Table B Col F",
8815/3/1,"Solitary fibrous tumor, malignant (C49_)",Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8821/1/1,Aggressive fibromatosis  (C49_),Borderline,"C499, All Other Sites","D48.1, See Topo Table B Col F",
8821/3/1,"Aggressive fibromatosis, malignant (C49_)",Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",Not listed in ICD-O-3.2
8822/1/1,Abdominal fibromatosis (C49_),Borderline,"C499, All Other Sites","D48.1, See Topo Table B Col F",
8822/3/1,"Abdominal fibrosis, malignant (C49_)",Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",Not listed in ICD-O-3.2
8823/1/1,Desmoplastic fibroma (C49_),Borderline,"C499, All Other Sites","D48.1, See Topo Table B Col F",
8823/3/1,Desmoplastic fibrosarcoma (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",Not listed in ICD-O-3.2
8824/1/1,Myofibromatosis (C49_),Borderline,"C499, All Other Sites","D48.1, See Topo Table B Col F",
8824/3/1,"Myofibroma, malignant (C49_)",Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",Not listed in ICD-O-3.2
8825/1/1,"Myofibroblastic tumor, NOS (C49_)",Borderline,"C499, All Other Sites","D48.1, See Topo Table B Col F",
8825/3/1,Myofibroblastic sarcoma (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8826/3/1,"Angiomyofibroblastoma, malignant (C49_)",Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",Not listed in ICD-O-3.2
8827/1/1,"Myofibroblastic tumor, peribronchial (C34_)",Borderline,"C349, All Other Sites","D38.1, See Topo Table B Col F",
8830/1/1,Atypical fibrous histiocytoma (C49_),Borderline,"C499, All Other Sites","D48.1, See Topo Table B Col F",
8830/3/1,Malignant fibrous histiocytoma (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8831/3/1,"Histiocytoma, NOS, malignant (C49_)",Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8832/1/1,"Dermatofibrosarcoma protuberans, NOS (C44_) (ICD-O-3.2 update, previously 8832/3)",Borderline,"C449, All Other Sites","D48.5, See Topo Table B Col F",
8832/3/1,"Dermatofibrosarcoma, NOS (C44_) (ICD-O-3.2 update, see 8832/1)",Malignant,"C449, All Other Sites","C44.9, See Topo Table B Col B",
8833/1/1,"Pigmented dermatofibrosarcoma protuberans (C44_) (ICD-O-3.2 update, previously 8833/3)",Borderline,"C449, All Other Sites","D48.5, See Topo Table B Col F",
8833/3/1,"Pigmented dermatofibrosarcoma protuberans (C44_) (ICD-O-3.2 update, see code 8833/1)",Malignant,"C449, All Other Sites","C44.9, See Topo Table B Col B",
8834/1/1,Giant cell fibroblastoma,Borderline,Specific Sites,See Topo Table B Col F,
8835/1/1,Plexiform fibrohistiocytic tumor,Borderline,Specific Sites,See Topo Table B Col F,
8835/3/1,Malignant plexiform fibrohistiocytic tumor,Malignant,Specific Sites,See Topo Table B Col B,Not listed in ICD-O-3.2
8836/1/1,Angiomatoid fibrous histiocytoma,Borderline,Specific Sites,See Topo Table B Col F,
8836/3/1,Malignant angiomatoid fibrous histiocytoma,Malignant,Specific Sites,See Topo Table B Col B,Not listed in ICD-O-3.2
8840/3/1,Myxosarcoma (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8841/1/1,"Angiomyxoma (C49_) (ICD-O-3.2 update, see code 8841/0)",Borderline,"C499, All Other Sites","D48.1, See Topo Table B Col F",
8841/3/1,"Angiomyxoma, malignant (C49_)",Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",Not listed in ICD-O-3.2
8842/3/1,"Ossifying fibromyxoid tumor, malignant",Malignant,Specific Sites,See Topo Table B Col B,
8850/1/1,Atypical lipomatous tumor (C49_),Borderline,"C499, All Other Sites","D48.1, See Topo Table B Col F",
8850/3/1,"Liposarcoma, NOS (C49_)",Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8851/1/1,Lipofibromatosis (ICD-O-3.2 update) (C49_),Borderline,"C499, All Other Sites","D48.1, See Topo Table B Col F",New code 2021+
8851/3/1,"Liposarcoma, well differentiated (C49_)",Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8852/3/1,Myxoid liposarcoma (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8853/3/1,Round cell liposarcoma (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8854/3/1,Pleomorphic liposarcoma (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8855/3/1,Mixed liposarcoma (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8857/3/1,Fibroblastic liposarcoma (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8858/3/1,Dedifferentiated liposarcoma (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8859/3/1,Myxoid pleomorphic liposarcoma (C49) (2022 update),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",New code 2022+
8860/1/1,"Angiomyolipoma, epithelioid (C49)",Borderline,"C499, All Other Sites","D48.1, See Topo Table B Col F",
8860/3/1,Angiomyoliposarcoma (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",Not listed in ICD-O-3.2
8890/1/1,"Leiomyomastosis, NOS (C54_)",Borderline,"C549, All Other Sites","D39.0, See Topo Table B Col F",
8890/3/1,"Leiomyosarcoma, NOS (C54_)",Malignant,"C549, All Other Sites","C54.9, See Topo Table B Col B",
8891/3/1,Epithelioid leiomyosarcoma (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8893/3/1,"Bizarre leiomyoma, malignant (C49_)",Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",Not listed in ICD-O-3.2
8894/3/1,Angiomyosarcoma (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8895/3/1,Myosarcoma (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8896/3/1,Myxoid leiomyosarcoma (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8897/1/1,Smooth muscle tumor of uncertain malignant potential (C49_),Borderline,"C499, All Other Sites","D48.1, See Topo Table B Col F",
8897/3/1,Malignant tumor of smooth muscle (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",Not listed in ICD-O-3.2
8898/1/1,Metastasizing leiomyoma (C49_),Borderline,"C499, All Other Sites","D48.1, See Topo Table B Col F",
8900/3/1,"Rhabdomyosarcoma, NOS (C49_)",Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8901/3/1,"Pleomorphic rhabdomyosarcoma, adult type (C49_)",Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8902/3/1,Mixed type rhabdomyosarcoma (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8910/3/1,"Embryonal rhabdomyosarcoma, NOS (C49_)",Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8912/3/1,Spindle cell rhabdomyosarcoma (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8920/3/1,Alveolar rhabdomyosarcoma (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8921/3/1,Ectomesenchymoma (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8930/3/1,"Endometrial stromal sarcoma, NOS (C541)",Malignant,"C541, All Other Sites","C54.1, See Topo Table B Col B",
8931/3/1,"Endometrial stroma sarcoma, low grade (C541)",Malignant,"C541, All Other Sites","C54.1, See Topo Table B Col B",
8933/3/1,Adenosarcoma,Malignant,Specific Sites,See Topo Table B Col B,
8934/3/1,Carcinofibroma,Malignant,Specific Sites,See Topo Table B Col B,
8935/1/1,"Stromal tumor, NOS (C541)",Borderline,"C541, All Other Sites","D39.0, See Topo Table B Col F",
8935/3/1,"Stromal sarcoma, NOS (C541)",Malignant,"C541, All Other Sites","C54.1, See Topo Table B Col B",
8936/1/1,"Gastrointestinal stromal tumor, NOS  (ICD-O-3.2 update, see code 8936/3)",Borderline,Specific Sites,See Topo Table B Col F,
8936/2/1,"Gastrointestinal stromal tumor, NOS, in situ (ICD-O-3.2 update, see code 8936/3)",In-Situ,Specific Sites,See Topo Table B Col D,
8936/3/1,Gastrointestinal stromal sarcoma,Malignant,Specific Sites,See Topo Table B Col B,
8940/3/1,"Mixed tumor, malignant, NOS (C07_, C08_)",Malignant,"C079, C089, All Other Sites","C07, C08.9, See Topo Table B Col B",
8941/2/1,"Carcinoma in situ in pleomorphic adenoma (C07_, C08_)",In-Situ,"C079, C089, All Other Sites","D00.0, See Topo Table B Col D",Not listed in ICD-O-3.2
8941/3/1,"Carcinoma ex pleomorphic adenoma (C07_, C08_)",Malignant,"C079, C089, All Other Sites","C07, C08.9, See Topo Table B Col B",
8950/3/1,Mullerian mixed tumor (C54_),Malignant,"C549, All Other Sites","C54.9, See Topo Table B Col B",
8951/3/1,Mesodermal mixed tumor (C220),Malignant,"C220, All Other Sites","C22.4, See Topo Table B Col B",
8959/1/1,Cystic partially differentiated nephroblastoma (C649),Borderline,"C649, All Other Sites","D41.0, See Topo Table B Col F",
8959/3/1,Malignant cystic nephroma (C649),Malignant,"C649, All Other Sites","C64, See Topo Table B Col B",
8960/1/1,Mesoblastic nephroma (C649),Borderline,"C649, All Other Sites","D41.0, See Topo Table B Col F",
8960/3/1,"Nephroblastoma, NOS (C649)",Malignant,"C649, All Other Sites","C64, See Topo Table B Col B",
8963/3/1,Rhabdoid tumor,Malignant,Specific Sites,See Topo Table B Col B,
8964/3/1,Clear cell sarcoma of kidney (C649),Malignant,"C649, All Other Sites","C64, See Topo Table B Col B",
8970/3/1,Hepatoblastoma (C220),Malignant,"C220, All Other Sites","C22.2, See Topo Table B Col B",
8971/3/1,Pancreastoblastoma (C25_),Malignant,"C259, All Other Sites","C25.9, See Topo Table B Col B",
8972/3/1,Pulmonary blastoma (C34_),Malignant,"C349, All Other Sites","C34.9, See Topo Table B Col B",
8973/3/1,Pleuropulmonary blastoma (C34_),Malignant,"C349, All Other Sites","C34.9, See Topo Table B Col B",
8974/1/1,Sialoblastoma,Borderline,Specific Sites,See Topo Table B Col F,
8975/1/1,Calcifying nested epithelial stromal tumor (C220),Borderline,"C220, All Other Sites","D37.6, See Topo Table B Col F",
8976/3/1,Gastroblastoma (C16) (2022 update),Malignant,"C169, All Other Sites","C16.9, See Topo Table B Col B",New code 2022+
8980/3/1,"Carcinosarcoma, NOS",Malignant,Specific Sites,See Topo Table B Col B,
8981/3/1,"Carcinosarcoma, embryonal",Malignant,Specific Sites,See Topo Table B Col B,
8982/3/1,Myoepithelial carcinoma,Malignant,Specific Sites,See Topo Table B Col B,
8983/2/1,"Adenomyoepithelioma, in situ (C50_)",In-Situ,"C509, All Other Sites","D05.8, See Topo Table B Col D",Not listed in ICD-O-3.2
8983/3/1,Adenomyoepithelioma with carcinoma (C50_),Malignant,"C509, All Other Sites","C50.9, See Topo Table B Col B",
8990/1/1,"Mesenchymoma, NOS (C49_)",Borderline,"C499, All Other Sites","D48.1, See Topo Table B Col F",
8990/3/1,"Mesenchymoma, malignant (C49_)",Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8991/3/1,Embryonal sarcoma (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
8996/3/1,"Medullary fibroma, malignant (C649)",Malignant,"C649, All Other Sites","C64, See Topo Table B Col B",Not listed in ICD-O-3.2
9000/1/1,"Brenner tumor, borderline malignancy (C569)",Borderline,"C569, All Other Sites","D39.1, See Topo Table B Col F",
9000/3/1,"Brenner tumor, malignant  (C569)",Malignant,"C569, All Other Sites","C56, See Topo Table B Col B",
9014/1/1,Serous adenofibroma of borderline malignancy (C569),Borderline,"C569, All Other Sites","D39.1, See Topo Table B Col F",
9014/2/1,"Serous adenocarcinofibroma, in situ (C569)",In-Situ,"C569, All Other Sites","D07.3, See Topo Table B Col D",Not listed in ICD-O-3.2
9014/3/1,Serous adenocarcinofibroma (C569),Malignant,"C569, All Other Sites","C56, See Topo Table B Col B",
9015/1/1,Mucinous adenofibroma of borderline malignancy (C569),Borderline,"C569, All Other Sites","D39.1, See Topo Table B Col F",
9015/2/1,"Mucinous adenofibroma, in situ",In-Situ,Specific sites,See Topo Table B Col D,Not listed in ICD-O-3.2
9015/3/1,Mucinous adenocarcinofibroma (c569),Malignant,"C569, All Other Sites","C56, See Topo Table B Col B",
9020/1/1,"Phyllodes tumor, borderline (C50_)",Borderline,"C509, All Other Sites","D48.6, See Topo Table B Col F",
9020/3/1,"Phyllodes tumor, malignant (C50_)",Malignant,"C509, All Other Sites","C50.9, See Topo Table B Col B",
9040/3/1,"Synovial sarcoma, NOS (C49_)",Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
9041/3/1,"Synovial sarcoma, spindle cell (C49_)",Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
9042/3/1,"Synovial sarcoma, epithelioid cell (C49_)",Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
9043/3/1,"Synovial sarcoma, biphasic (C49_)",Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
9044/3/1,"Clear cell sarcoma, NOS  (C49_)",Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
9045/3/1,"Biphenotypic sinonasal sarcoma (C300, C31_) (ICD-O-3.2 update)",Malignant,"C300, C319, All Other Sites","C30.0, C31.9, See Topo Table B Col B",New code 2021+
9050/2/1,"Mesothelioma, in situ  (2023 update)",In-Situ,Specific Sites,See Topo Table B Col D,
9050/3/1,"Mesothelioma, malignant (C384)",Malignant,"C384, All Other Sites","C45.2, See Topo Table B Col J",
9051/3/1,"Fibrous mesothelioma, malignant (C384)",Malignant,"C384, All Other Sites","C45.2, See Topo Table B Col J",
9052/1/1,"Well differentiated papillary mesothelioma, pleura (ICD-O-3.2 update) (C384)",Borderline,"C384, All Other Sites","D38.2, See Topo Table B Col F",
9052/3/1,"Epithelioid mesothelioma, malignant (C384)",Malignant,"C384, All Other Sites","C45.2, See Topo Table B Col J",
9053/3/1,"Mesothelioma, biphasic, malignant (C384)",Malignant,"C384, All Other Sites","C45.2, See Topo Table B Col J",
9055/1/1,"Cystic mesothelioma, NOS (C48_) (ICD-O-3.2 update, see code 9055/0)",Borderline,"C488, All Other Sites","D48.4, See Topo Table B Col F",
9055/3/1,"Multicystic mesothelioma, malignant (C384)",Malignant,"C384, All Other Sites","C45.2, See Topo Table B Col J",
9060/2/1,"Dysgerminoma, in situ (C569 [F], C62_[M])",In-Situ,"C569 [F], C629 [M], All Other Sites","D07.3 (F), D07.6 (M), See Topo Table B Col D",Not listed in ICD-O-3.2
9060/3/1,"Dysgerminoma (C569 [F], C62_[M])",Malignant,"C569 [F], C629 [M], All Other Sites","C56 [F], C62.9 [M], See Topo Table B Col B",
9061/2/1,"Seminoma, in situ (C62_)",In-Situ,"C629, All Other Sites","D07.6, See Topo Table B Col D",Not listed in ICD-O-3.2
9061/3/1,"Seminoma, NOS (C62_)",Malignant,"C629, All Other Sites","C62.9, See Topo Table B Col B",
9062/3/1,"Seminoma, anaplastic (C62_)",Malignant,"C629, All Other Sites","C62.9, See Topo Table B Col B",
9063/2/1,"Spermatocytic seminoma, in situ (C62_)",In-Situ,"C629, All Other Sites","D07.6, See Topo Table B Col D",Not listed in ICD-O-3.2
9063/3/1,Spermatocytic seminoma (C62_),Malignant,"C629, All Other Sites","C62.9, See Topo Table B Col B",
9064/2/1,Intratubular malignant germ cells (C62_),In-Situ,"C629, All Other Sites","D07.6, See Topo Table B Col D",
9064/3/1,Germinoma (C62_),Malignant,"C629, All Other Sites","C62.9, See Topo Table B Col B",
9065/2/1,"Germ cell tumor, nonseminomatous, in situ",In-Situ,Specific sites,See Topo Table B Col D,Not listed in ICD-O-3.2
9065/3/1,"Germ cell tumor, nonseminomatous (C62_)",Malignant,"C629, All Other Sites","C62.9, See Topo Table B Col B",
9070/2/1,"Embryonal carcinoma, NOS, in situ",In-Situ,Specific sites,See Topo Table B Col D,Not listed in ICD-O-3.2
9070/3/1,"Embryonal carcinoma, NOS",Malignant,Specific Sites,See Topo Table B Col B,
9071/3/1,"Yolk sac tumor (C569 [F], C62_[M])",Malignant,"C569 [F], C629 [M], All Other Sites","C56 [F], C62.9 [M], See Topo Table B Col B",
9072/3/1,Polyembryoma,Malignant,Specific Sites,See Topo Table B Col B,
9073/1/1,"Gonadoblastoma (C569 [F], C62_[M])",Borderline,"C569 [F], C629 [M], All Other Sites","D39.1 [F], D40.1 [M], See Topo Table B Col F",
9073/3/1,"Gonadoblastoma, malignant (C569 [F], C62_[M])",Malignant,"C569 [F], C629 [M], All Other Sites","C56 [F], C62.9 [M], See Topo Table B Col B",Not listed in ICD-O-3.2
9080/1/1,"Teratoma, NOS (ICD-O-3.2 update)",Borderline,Specific Sites,See Topo Table B Col F,
9080/2/1,"Teratoma, in situ",In-Situ,Specific sites,See Topo Table B Col D,Not listed in ICD-O-3.2
9080/3/1,"Teratoma, malignant, NOS (ICD-O-3.2 update, see 9080/1 for specific sites: C34, C37, 73)",Malignant,Specific Sites,See Topo Table B Col B,
9081/3/1,Teratocarcinoma (C220),Malignant,"C220, All Other Sites","C22.7, See Topo Table B Col B",
9082/3/1,"Malignant teratoma, undifferentiated",Malignant,Specific Sites,See Topo Table B Col B,
9083/3/1,"Malignant teratoma, intermediate",Malignant,Specific Sites,See Topo Table B Col B,
9084/3/1,Teratoma with malignant transformation,Malignant,Specific Sites,See Topo Table B Col B,
9085/2/1,"Mixed germ cell tumor, in situ",In-Situ,Specific sites,See Topo Table B Col D,Not listed in ICD-O-3.2
9085/3/1,Mixed germ cell tumor,Malignant,Specific Sites,See Topo Table B Col B,
9086/3/1,Germ cell tumor with associated hematological malignancy (ICD-O-3.2 update),Malignant,Specific Sites,See Topo Table B Col B,New code 2021+
9090/2/1,"Struma ovarii, in situ",In-Situ,Specific sites,See Topo Table B Col D,Not listed in ICD-O-3.2
9090/3/1,"Struma ovarii, malignant  (C569)",Malignant,"C569, All Other Sites","C56, See Topo Table B Col B",
9091/1/1,Strumal carcinoid (C569),Borderline,"C569, All Other Sites","D39.1, See Topo Table B Col F",
9091/3/1,"Strumal carcinoid, malignant  (C569)",Malignant,"C569, All Other Sites","C56, See Topo Table B Col B",Not listed in ICD-O-3.2
9100/1/1,Invasive hydatidiform mole (C589),Borderline,"C589, All Other Sites","D39.2, See Topo Table B Col F",
9100/2/1,"Choriocarcinoma in situ, NOS (C589)",In-Situ,"C589, All Other Sites","D07.3, See Topo Table B Col D",Not listed in ICD-O-3.2
9100/3/1,"Choriocarcinoma, NOS  (C589)",Malignant,"C589, All Other Sites","C58, See Topo Table B Col B",
9101/2/1,"Choriocarcinoma combined with other germ cell elements, in situ (C589)",In-Situ,"C589, All Other Sites","D07.3, See Topo Table B Col D",Not listed in ICD-O-3.2
9101/3/1,Choriocarcinoma combined with other germ cell elements,Malignant,Specific Sites,See Topo Table B Col B,
9102/3/1,"Malignant teratoma, trophoblastic (C62_)",Malignant,"C629, All Other Sites","C62.9, See Topo Table B Col B",
9103/3/1,"Partial hydatidiform mole, malignant (C589)",Malignant,"C589, All Other Sites","C58, See Topo Table B Col B",Not listed in ICD-O-3.2
9104/1/1,Placental site trophoblastic tumor (C589),Borderline,"C589, All Other Sites","D39.2, See Topo Table B Col F",
9104/3/1,Malignant placental site trophoblastic tumor (C589),Malignant,"C589, All Other Sites","C58, See Topo Table B Col B",Not listed in ICD-O-3.2
9105/3/1,"Trophoblastic tumor, epithelioid",Malignant,Specific Sites,See Topo Table B Col B,
9110/1/1,Wolffian tumor,Borderline,Specific Sites,See Topo Table B Col F,
9110/3/1,"Wolffian tumor, malignant",Malignant,Specific Sites,See Topo Table B Col B,
9111/3/1,Mesonephric-like adenocarcinoma (2022 update),Malignant,Specific Sites,See Topo Table B Col B,New code 2022+
9120/1/1,"Hemangioma, NOS, borderline",Borderline,All sites,D18.0,Not listed in ICD-O-3.2
9120/3/1,Hemangiosarcoma (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
9121/1/1,"Cavernous hemangioma, borderline",Borderline,All sites,D18.0,Not listed in ICD-O-3.2
9124/3/1,Kupffer cell sarcoma (C220),Malignant,"C220, All Other Sites","C22.3, See Topo Table B Col B",
9125/3/1,"Epithelioid hemangioma, malignant (C49_)",Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",Not listed in ICD-O-3.2
9130/1/1,"Hemangioendothelioma, borderline (C49_)",Borderline,Specific Sites,See Topo Table B Col F,Not listed in ICD-O-3.2
9130/3/1,"Hemangioendothelioma, malignant (C49_)",Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
9133/1/1,"Epithelioid hemangioendothelioma, NOS (ICD-O-3.2 update, see code 9133/3)",Borderline,Specific Sites,See Topo Table B Col F,
9133/3/1,"Epithelioid hemangioendothelioma, malignant (ICD-O-3 update, previously 9133/1)",Malignant,Specific Sites,See Topo Table B Col B,
9135/1/1,Papillary intralymphatic angioendothelioma,Borderline,Specific Sites,See Topo Table B Col F,
9136/1/1,Spindle cell hemangioendothelioma,Borderline,Specific Sites,See Topo Table B Col F,
9137/3/1,Intimal sarcoma (ICD-O-3.2 update),Malignant,Specific Sites,See Topo Table B Col B,New code 2021+
9138/1/1,Pseudomyogenic (epithelioid sarcoma-like) hemagioendothelioma (ICD-O-3.2 update),Borderline,Specific Sites,See Topo Table B Col F,New code 2021+
9140/3/1,Kaposi Sarcoma,Malignant,Specific Sites,See Topo Table B Col K,
9150/1/1,"Hemangiopericytoma, NOS (C49_) (ICD-O-3.2 update, see code 8815/1)",Borderline,"C499, All Other Sites","D48.1, See Topo Table B Col F",
9150/3/1,"Hemangiopericytoma, malignant (C49_) (ICD-O-3.2 update, see code 8815/3)",Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
9161/1/1,Hemangioblastoma (C49_),Borderline,"C499, All Other Sites","D48.1, See Topo Table B Col F",
9161/3/1,"Hemangioblastoma, malignant (C49_)",Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",Not listed in ICD-O-3.2
9170/3/1,Lymphangiosarcoma (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
9174/1/1,Lymphangiomyomatosis (C49_),Borderline,"C499, All Other Sites","D48.1, See Topo Table B Col F",
9174/3/1,Lymphangioleiomyomatosis (C49) (2022 update),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
9175/3/1,Hemolymphangiosarcoma,Malignant,Specific Sites,See Topo Table B Col B,Not listed in ICD-O-3.2
9180/3/1,"Osteosarcoma, NOS (C40_, C41_)",Malignant,"C409, C419, All Other Sites","C40.9, C41.9, See Topo Table B Col B",
9181/3/1,"Chondroblastic osteosarcoma  (C40_, C41_)",Malignant,"C409, C419, All Other Sites","C40.9, C41.9, See Topo Table B Col B",
9182/3/1,"Fibroblastic osteosarcoma (C40_, C41_)",Malignant,"C409, C419, All Other Sites","C40.9, C41.9, See Topo Table B Col B",
9183/3/1,"Telangiectatic osteosarcoma (C40_, C41_)",Malignant,"C409, C419, All Other Sites","C40.9, C41.9, See Topo Table B Col B",
9184/3/1,"Osteosarcoma in Paget disease of bone  (C40_, C41_)",Malignant,"C409, C419, All Other Sites","C40.9, C41.9, See Topo Table B Col B",
9185/3/1,"Small cell osteosarcoma (C40_, C41_)",Malignant,"C409, C419, All Other Sites","C40.9, C41.9, See Topo Table B Col B",
9186/3/1,"Central osteosarcoma (C40_, C41_)",Malignant,"C409, C419, All Other Sites","C40.9, C41.9, See Topo Table B Col B",
9187/3/1,"Low grade central osteosarcoma (C40_, C41_)",Malignant,"C409, C419, All Other Sites","C40.9, C41.9, See Topo Table B Col B",
9192/3/1,"Parosteal osteosarcoma (C40_, C41_)",Malignant,"C409, C419, All Other Sites","C40.9, C41.9, See Topo Table B Col B",
9193/3/1,"Periosteal osteosarcoma (C40_, C41_)",Malignant,"C409, C419, All Other Sites","C40.9, C41.9, See Topo Table B Col B",
9194/3/1,"High grade surface osteosarcoma (C40_, C41_)",Malignant,"C409, C419, All Other Sites","C40.9, C41.9, See Topo Table B Col B",
9195/3/1,"Intracortical osteosarcoma (C40_, C41_)",Malignant,"C409, C419, All Other Sites","C40.9, C41.9, See Topo Table B Col B",
9200/1/1,"Aggressive osteoblastoma (C40_, C41_)",Borderline,"C409, C419, All Other Sites","D48.0, See Topo Table B Col F",
9200/3/1,"Osteosarcoma, malignant (C40_, C41_)",Malignant,"C409, C419, All Other Sites","C40.9, C41.9, See Topo Table B Col B",Not listed in ICD-O-3.2
9210/1/1,"Osteochondromatosis, NOS (C40_, C41_)",Borderline,"C409, C419, All Other Sites","D48.0, See Topo Table B Col F",
9220/1/1,"Chondromatosis, NOS (C40_, C41_)",Borderline,"C409, C419, All Other Sites","D48.0, See Topo Table B Col F",
9220/3/1,"Chondrosarcoma, NOS (C40_, C41_)",Malignant,"C409, C419, All Other Sites","C40.9, C41.9, See Topo Table B Col B",
9221/3/1,"Periosteal chondrosarcoma (C40_, C41_)",Malignant,"C409, C419, All Other Sites","C40.9, C41.9, See Topo Table B Col B",
9222/1/1,"Atypical cartilaginous tumor (C40_, C41_) (ICD-O-3.2 update)",Borderline,"C409, C419, All Other Sites","D48.0, See Topo Table B Col F",New code 2021+
9222/3/1,"Chondrosarcoma, grade 1 (C40_, C41) (2022 update)",Malignant,"C409, C419, All Other Sites","C40.9, C41.9, See Topo Table B Col B",New code 2022+
9230/1/1,"Chrondroblastoma, NOS (C40_, C41_) (ICD-O-3.2 update, previously 9230/0)",Borderline,"C409, C419, All Other Sites","D48.0, See Topo Table B Col F",
9230/3/1,"Chondroblastoma, malignant (C40_, C41_)",Malignant,"C409, C419, All Other Sites","C40.9, C41.9, See Topo Table B Col B",
9231/3/1,"Myxoid chondrosarcoma (C40_, C41_)",Malignant,"C409, C419, All Other Sites","C40.9, C41.9, See Topo Table B Col B",
9240/3/1,Mesenchymal chondrosarcoma (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
9242/3/1,"Clear cell chondrosarcoma (C40_, C41_)",Malignant,"C409, C419, All Other Sites","C40.9, C41.9, See Topo Table B Col B",
9243/3/1,"Dedifferentiated chondrosarcoma (C40_, C41_)",Malignant,"C409, C419, All Other Sites","C40.9, C41.9, See Topo Table B Col B",
9250/1/1,"Giant cell tumor of bone, NOS (C40_, C41_)",Borderline,"C409, C419, All Other Sites","D48.0, See Topo Table B Col F",
9250/3/1,"Giant cell tumor of bone, malignant (C40_, C41_)",Malignant,"C409, C419, All Other Sites","C40.9, C41.9, See Topo Table B Col B",
9251/1/1,"Giant cell tumor of soft parts, NOS (C49_)",Borderline,"C499, All Other Sites","D48.1, See Topo Table B Col F",
9251/3/1,Malignant giant cell tumor of soft parts (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
9252/1/1,"Tenosynovial giant cell tumor, diffuse  (C49_) (ICD-O-3.2 update)",Borderline,"C499, All Other Sites","D48.1, See Topo Table B Col F",New code 2021+
9252/3/1,Malignant tenosynovial giant cell tumor  (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
9260/3/1,"Ewing sarcoma (C40_, C41_) (ICD-O-3.2 update, see 9364/3)",Malignant,"C409, C419, All Other Sites","C40.9, C41.9, See Topo Table B Col B",
9261/1/1,"Osteofibrous dysplasia-like adamantinoma  (C40_, C41_) (2022 update)",Borderline,"C409, C419, All Other Sites","D48.0, See Topo Table B Col F",Not listed in ICD-O-3.2
9261/3/1,"Adamantinoma of long bones (C40_, C41_)",Malignant,"C409, C419, All Other Sites","C40.9, C41.9, See Topo Table B Col B",
9270/1/1,"Odontogenic tumor, NOS (C41_)",Borderline,"C419, All Other Sites","D48.0, See Topo Table B Col F",
9270/3/1,"Odontogenic tumor, malignant (C41_)",Malignant,"C419, All Other Sites","C41.9, See Topo Table B Col B",
9282/3/1,Complex odontosarcoma (C41_),Malignant,"C419, All Other Sites","C41.9, See Topo Table B Col B",Not listed in ICD-O-3.2
9290/3/1,Ameloblastic odontosarcoma (C41_),Malignant,"C419, All Other Sites","C41.9, See Topo Table B Col B",
9302/3/1,Ghost cell odontogenic carcinoma (ICD-O-3.2 update),Malignant,Specific Sites,See Topo Table B Col B,
9310/3/1,"Ameloblastoma, metastasizing (C41_)",Malignant,"C419, All Other Sites","C41.9, See Topo Table B Col B",
9312/3/1,"Squamous odontogenic tumor, malignant (C41_)",Malignant,"C419, All Other Sites","C41.9, See Topo Table B Col B",Not listed in ICD-O-3.2
9321/3/1,Cental odontogenic fibrosarcoma,Malignant,Specific Sites,See Topo Table B Col B,Not listed in ICD-O-3.2
9330/3/1,Ameloblastic fibrosarcoma (C41_),Malignant,"C419, All Other Sites","C41.9, See Topo Table B Col B",
9340/3/1,"Calcifying epithelial odontogenic tumor, malignant (C41_)",Malignant,"C419, All Other Sites","C41.9, See Topo Table B Col B",Not listed in ICD-O-3.2
9341/1/1,Clear cell odontogenic tumor (C41_) (ICD-O-3.2 update),Borderline,"C419, All Other Sites","D48.0, See Topo Table B Col F",
9341/3/1,Clear cell odontogenic tumor (C41_),Malignant,"C419, All Other Sites","C41.9, See Topo Table B Col B",
9342/3/1,Odontogenic carcinosarcoma (C41_),Malignant,"C419, All Other Sites","C41.9, See Topo Table B Col B",
9350/1/1,Craniopharyngioma (C752),Borderline,"C752, All Other Sites","D44.3, See Topo Table B Col F",
9350/3/1,"Craniopharyngioma, malignant (C752)",Malignant,"C752, All Other Sites","C75.2, See Topo Table B Col B",Not listed in ICD-O-3.2
9351/1/1,"Craniopharyngioma, adamantinomatous (C752)",Borderline,"C752, All Other Sites","D44.3, See Topo Table B Col F",
9351/3/1,"Craniopharyngioma, adamantinomatous, malignant (C752)",Malignant,"C752, All Other Sites","C75.2, See Topo Table B Col B",Not listed in ICD-O-3.2
9352/1/1,"Craniopharyngioma, papillary (C752)",Borderline,"C752, All Other Sites","D44.3, See Topo Table B Col F",
9352/3/1,"Craniopharyngioma, papillary, malignant (C752)",Malignant,"C752, All Other Sites","C75.2, See Topo Table B Col B",Not listed in ICD-O-3.2
9360/1/1,"Pinealoma, NOS (C753)",Borderline,"C753, All Other Sites","D44.5, See Topo Table B Col F",
9360/3/1,"Pinealoma, malignant (C753)",Malignant,"C753, All Other Sites","C75.3, See Topo Table B Col B",Not listed in ICD-O-3.2
9361/1/1,Pineocytoma (C753),Borderline,"C753, All Other Sites","D44.5, See Topo Table B Col F",Not listed in ICD-O-3.2
9361/3/1,"Pineocytoma, malignant (C753)",Malignant,"C753, All Other Sites","C75.3, See Topo Table B Col B",
9362/3/1,Pineoblastoma (C753),Malignant,"C753, All Other Sites","C75.3, See Topo Table B Col B",
9363/3/1,"Melanotic neuroectodermal tumor, malignant (C40_, C41_)",Malignant,"C409, C419, All Other Sites","C40.9, C41.9, See Topo Table B Col B",Not listed in ICD-O-3.2
9364/3/1,"Ewing sarcoma (C40_, C41_) (ICD-O-3.2 update, name changed and previous code 9260/3 deleted and moved to this code)",Malignant,"C409, C419, All Other Sites","C40.9, C41.9, See Topo Table B Col B",
9365/3/1,Askin tumor,Malignant,Specific Sites,See Topo Table B Col B,
9366/3/1,"Round cell sarcoma with EWSR1-non ETS fusions (C40_, C41_) (2022 update)",Malignant,"C409, C419, All Other Sites","C40.9, C41.9, See Topo Table B Col B",New code 2022+
9367/3/1,"CIC-rearranged sarcoma (C40_, C41_) (2022 update)",Malignant,"C409, C419, All Other Sites","C40.9, C41.9, See Topo Table B Col B",New code 2022+
9368/3/1,"Sarcoma with BCOR genetic alterations (C40_, C41_) (2022 update)",Malignant,"C409, C419, All Other Sites","C40.9, C41.9, See Topo Table B Col B",New code 2022+
9370/3/1,"Chordoma, NOS (C40_, C41_)",Malignant,"C409, C419, All Other Sites","C40.9, C41.9, See Topo Table B Col B",
9371/3/1,"Chondroid chordoma (C40_, C41_)",Malignant,"C409, C419, All Other Sites","C40.9, C41.9, See Topo Table B Col B",
9372/3/1,"Dedifferentiated chordoma (C40_, C41_)",Malignant,"C409, C419, All Other Sites","C40.9, C41.9, See Topo Table B Col B",
9380/1/1,"Glioma, borderline (C71_)",Borderline,"C719, All Other Sites","D43.2, See Topo Table B Col F",Not listed in ICD-O-3.2
9380/3/1,"Glioma, malignant (C71_)",Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",
9381/3/1,Gliomatosis cerebri (C71_),Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",
9382/3/1,"Oligoastrocytoma, NOS (C71_)",Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",
9383/1/1,Subependymoma (C71_),Borderline,"C719, All Other Sites","D43.2, See Topo Table B Col F",
9383/3/1,"Subependymoma, malignant (C71_)",Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",Not listed in ICD-O-3.2
9384/1/1,Supependymal giant cell astrocytoma (C71_),Borderline,"C719, All Other Sites","D43.2, See Topo Table B Col F",
9384/3/1,"Supependymal giant cell astrocytoma, malignant (C71_)",Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",Not listed in ICD-O-3.2
9385/3/1,"Diffuse midline glioma, H3 K27M-mutation (C71_) (ICD-O-3.2 update)",Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",
9390/1/1,Atypical choroid plexus papilloma (C715),Borderline,"C715, All Other Sites","D43.0, See Topo Table B Col F",
9390/3/1,Choroid plexus papilloma (C715),Malignant,"C715, All Other Sites","C71.5, See Topo Table B Col B",
9391/1/1,Sellar ependymoma (C751) (ICD-O-3.2 update),Borderline,"C751, All Other Sites","D44.3, See Topo Table B Col F",
9391/3/1,"Ependymoma, NOS (C71_)",Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",
9392/3/1,"Ependymoma, anaplastic (C71_)",Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",
9393/1/1,"Papillary ependymoma, borderline (C71_)",Borderline,"C719, All Other Sites","D43.2, See Topo Table B Col F",Not listed in ICD-O-3.2
9393/3/1,Papillary ependymoma (C71_),Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",
9394/1/1,Myxopapillary ependymoma (C71_),Borderline,"C719, All Other Sites","D43.2, See Topo Table B Col F",
9394/3/1,"Myxopapillary ependymoma, malignant (C71_)",Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",Not listed in ICD-O-3.2
9395/3/1,Papillary tumor of the pineal region,Malignant,Specific Sites,See Topo Table B Col B,
9396/3/1,"Ependymoma, RELA fusion-positive (C71_) (ICD-O-3.2 update)",Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",
9400/1/1,"Astrocytoma, borderline (C71_)",Borderline,"C719, All Other Sites","D43.2, See Topo Table B Col F",Not listed in ICD-O-3.2
9400/3/1,"Astrocytoma, NOS (C71_)",Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",
9401/3/1,"Astrocytoma, anaplastic (C71_)",Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",
9410/3/1,Protoplasmic astrocytoma (C71_),Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",
9411/3/1,Gemistocytic astrocytoma (C71_),Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",
9412/1/1,Desmoplastic infantile astrocytoma (C71_),Borderline,"C719, All Other Sites","D43.2, See Topo Table B Col F",
9412/3/1,"Desmoplastic infantile astrocytoma, malignant (C71_)",Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",Not listed in ICD-O-3.2
9413/1/1,"Dysembryoplastic neuroepithelial tumor, borderline",Borderline,Specific Sites,See Topo Table B Col F,Not listed in ICD-O-3.2
9413/3/1,"Dysembryoplastic neuroepithelial tumor, malignant",Malignant,Specific Sites,See Topo Table B Col B,Not listed in ICD-O-3.2
9420/3/1,Fibrillary astrocytoma (C71_),Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",
9421/1/1,Pilocytic astrocytoma  (C71_) (2023+),Borderline,"C719, All Other Sites","D43.2, See Topo Table B Col F",
9421/3/1,"Pilocytic astrocytoma, malignant  (C71_) (2001-2022)",Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",
9421/3/1,High-grade astrocytoma with piloid features (HGAP) (C71_) (2023 update),Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",
9423/3/1,Polar spongioblastoma  (C71_),Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",
9424/3/1,Pleomorphic xanthoastrocytoma  (C71_),Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",
9425/3/1,Pilomyxoid astrocytoma (C71_),Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",
9430/3/1,Astroblastoma  (C71_),Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",
9431/1/1,Angiocentric glioma (C71_),Borderline,"C719, All Other Sites","D43.2, See Topo Table B Col F",
9432/1/1,Pituicytoma (C751),Borderline,"C751, All Other Sites","D44.3, See Topo Table B Col F",
9440/1/1,"Glioblastoma, NOS, borderline (C71_)",Borderline,"C719, All Other Sites","D43.2, See Topo Table B Col F",Not listed in ICD-O-3.2
9440/3/1,"Glioblastoma, NOS  (C71_)",Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",
9441/3/1,Giant cell glioblastoma  (C71_),Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",
9442/1/1,Gliofibroma  (C71_),Borderline,"C719, All Other Sites","D43.2, See Topo Table B Col F",
9442/3/1,Gliosarcoma  (C71_),Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",
9444/1/1,Chordoid glioma  (C71_),Borderline,"C719, All Other Sites","D43.2, See Topo Table B Col F",
9444/3/1,"Choriod glioma of third venricle, malignant (C71_)",Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",Not listed in ICD-O-3.2
9445/3/1,"Glioblastoma, IDH-mutant (C71_)",Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",
9450/1/1,"Oligodendroglioma, borderline (C71_)",Borderline,"C719, All Other Sites","D43.2, See Topo Table B Col F",Not listed in ICD-O-3.2
9450/3/1,"Oligodendroglioma, NOS  (C71_)",Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",
9451/3/1,"Oligodendroglioma, anaplastic  (C71_)",Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",
9460/3/1,Oligodendroblastoma  (C71_),Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",
9470/3/1,"Medulloblastoma, NOS (C716)",Malignant,"C716, All Other Sites","C71.6, See Topo Table B Col B",
9471/3/1,Desmoplastic nodular medulloblastoma (C716),Malignant,"C716, All Other Sites","C71.6, See Topo Table B Col B",
9472/3/1,Medullomyoblastoma (C716),Malignant,"C716, All Other Sites","C71.6, See Topo Table B Col B",
9473/3/1,"CNS embryonal tumor, NOS (C716)",Malignant,"C716, All Other Sites","C71.6, See Topo Table B Col B",
9474/3/1,Large cell medulloblastoma (C716),Malignant,"C716, All Other Sites","C71.6, See Topo Table B Col B",
9475/3/1,"Medulloblastoma, WNT-activated, NOS (C716) (ICD-O-3.2 update)",Malignant,"C716, All Other Sites","C71.6, See Topo Table B Col B",New code 2021+
9476/3/1,"Medulloblastoma, SHH-activated and TP53-mutant (C716) (ICD-O-3.2 update)",Malignant,"C716, All Other Sites","C71.6, See Topo Table B Col B",New code 2021+
9477/3/1,"Medulloblastoma, non-WNT/non-SHH (C716) (ICD-O-3.2 update)",Malignant,"C716, All Other Sites","C71.6, See Topo Table B Col B",New code 2021+
9478/3/1,Embryonal tumor with multilayered rosettes with C19MC alteration (C71_) (ICD-O-3.2 update),Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",New code 2021+
9480/3/1,"Cerebellar sarcoma, NOS (C716)",Malignant,"C716, All Other Sites","C71.6, See Topo Table B Col B",
9490/1/1,"Ganglioneuroma, borderline (C49_)",Borderline,"C499, All Other Sites","D48.1, See Topo Table B Col F",Not listed in ICD-O-3.2
9490/3/1,Ganglioneuroblastoma (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
9500/2/1,"Neuroblastoma, NOS, in situ",In-Situ,Specific sites,See Topo Table B Col D,Not listed in ICD-O-3.2
9500/3/1,"Neuroblastoma, NOS",Malignant,Specific Sites,See Topo Table B Col B,
9501/3/1,"Medulloepithelioma, NOS (C694)",Malignant,"C694, All Other Sites","C69.4, See Topo Table B Col B",
9502/3/1,"Teratoid medulloepithelioma, NOS",Malignant,Specific Sites,See Topo Table B Col B,
9503/3/1,"Neuroepithelioma, NOS",Malignant,Specific Sites,See Topo Table B Col B,
9504/3/1,Spongioneuroblastoma,Malignant,Specific Sites,See Topo Table B Col B,
9505/1/1,"Ganglioglioma, NOS",Borderline,Specific Sites,See Topo Table B Col F,
9505/3/1,"Ganglioglioma, anaplastic",Malignant,Specific Sites,See Topo Table B Col B,
9506/1/1,Central neurocytoma,Borderline,Specific Sites,See Topo Table B Col F,
9506/3/1,"Neurocytoma, malignant",Malignant,Specific Sites,See Topo Table B Col B,Not listed in ICD-O-3.2
9508/3/1,Atypical teratoid/rhabdoid tumor (C71_),Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",
9509/1/1,Papillary glioneuronal tumor,Borderline,Specific Sites,See Topo Table B Col F,
9509/3/1,Diffuse leptomeningeal glioneuronal tumor (C71_) (2023 update),Malignant,"C719, All Other Sites","C71.9, See Topo Table B Col B",Not listed in ICD-O-3.2
9510/3/1,"Retinoblastoma, NOS (C692)",Malignant,"C692, All Other Sites","C69.2, See Topo Table B Col B",
9511/3/1,"Retinoblastoma, differentiated (C692)",Malignant,"C692, All Other Sites","C69.2, See Topo Table B Col B",
9512/3/1,"Retinoblastoma, undifferentiated (C692)",Malignant,"C692, All Other Sites","C69.2, See Topo Table B Col B",
9513/3/1,"Retinoblastoma, diffuse (C692)",Malignant,"C692, All Other Sites","C69.2, See Topo Table B Col B",
9514/1/1,"Retinoblastoma, spontaneously regressed (C692)",Borderline,"C692, All Other Sites","D48.7, See Topo Table B Col F",
9520/3/1,Olfactory neurogenic tumor (C300),Malignant,"C300, All Other Sites","C30.0, See Topo Table B Col B",
9521/3/1,Olfactory neurocytoma  (C300),Malignant,"C300, All Other Sites","C30.0, See Topo Table B Col B",
9522/3/1,Olfactory neuroblastoma  (C300),Malignant,"C300, All Other Sites","C30.0, See Topo Table B Col B",
9523/3/1,Olfactory neuroepithelioma  (C300),Malignant,"C300, All Other Sites","C30.0, See Topo Table B Col B",
9530/1/1,"Meningiomatosis, NOS (ICD-O-3.2 update) (C70_)",Borderline,"C709, All Other Sites","D42.9, See Topo Table B Col F",Not listed in ICD-O-3.2
9530/3/1,"Meningioma, malignant  (C70_)",Malignant,"C709, All Other Sites","C70.9, See Topo Table B Col B",
9531/1/1,"Meningiothelial meningioma, borderline (C70_)",Borderline,"C709, All Other Sites","D42.9, See Topo Table B Col F",Not listed in ICD-O-3.2
9531/3/1,"Meningiothelial meningioma, malignant (C70_)",Malignant,"C709, All Other Sites","C70.9, See Topo Table B Col B",Not listed in ICD-O-3.2
9532/3/1,"Fibrous meningioma, malignant (C70_)",Malignant,"C709, All Other Sites","C70.9, See Topo Table B Col B",Not listed in ICD-O-3.2
9533/3/1,"Psammomatous meningioma, malignant (C70_)",Malignant,"C709, All Other Sites","C70.9, See Topo Table B Col B",Not listed in ICD-O-3.2
9534/3/1,"Angiomatous meningioma, malignant (C70_)",Malignant,"C709, All Other Sites","C70.9, See Topo Table B Col B",Not listed in ICD-O-3.2
9535/3/1,"Hemangioblastic meningioma, malignant (C70_)",Malignant,"C709, All Other Sites","C70.9, See Topo Table B Col B",Not listed in ICD-O-3.2
9537/1/1,"Mixed mengioma, borderline (C70_)",Borderline,"C709, All Other Sites","D42.9, See Topo Table B Col F",Not listed in ICD-O-3.2
9537/3/1,"Transitional meningioma, malignant (C70_)",Malignant,"C709, All Other Sites","C70.9, See Topo Table B Col B",Not listed in ICD-O-3.2
9538/1/1,Clear cell meningioma (C70_),Borderline,"C709, All Other Sites","D42.9, See Topo Table B Col F",
9538/3/1,Papillary meningioma (C70_),Malignant,"C709, All Other Sites","C70.9, See Topo Table B Col B",
9539/1/1,Atypical meningioma (C70_),Borderline,"C709, All Other Sites","D42.9, See Topo Table B Col F",
9539/3/1,Meningeal sarcomatosis (C70_),Malignant,"C709, All Other Sites","C70.9, See Topo Table B Col B",
9540/1/1,"Neurofibromatosis, NOS (ICD-O-3.2 update, code deleted)",Borderline,All Sites,Q85.0,
9540/3/1,"Malignant peripheral nerve sheath tumor, NOS",Malignant,Specific Sites,See Topo Table B Col B,
9542/3/1,"Malignant peripheral nerve sheath tumor, epithelioid (ICD-O-3.2 update)",Malignant,Specific Sites,See Topo Table B Col B,New code 2021+
9560/1/1,"Melanotic schwannoma (ICD-O-3.2, now includes 9560/0)",Borderline,Specific Sites,See Topo Table B Col F,
9560/3/1,"Neurilemoma, malignant",Malignant,Specific Sites,See Topo Table B Col B,
9561/3/1,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation,Malignant,Specific Sites,See Topo Table B Col B,
9562/3/1,"Neurothekeoma, malignant",Malignant,Specific Sites,See Topo Table B Col B,
9571/3/1,"Perineurioma, malignant",Malignant,Specific Sites,See Topo Table B Col B,
9580/3/1,"Granular cell tumor, malignant (C49_)",Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
9581/3/1,Alveolar soft part sarcoma (C49_),Malignant,"C499, All Other Sites","C49.9, See Topo Table B Col B",
9590/3/1,"Malignant lymphoma, NOS",Malignant,All Sites,C85.9,
9591/1/1,"Monoclonal B-cell lymphocytosis, NOS (ICD-O-3.2 update)",Malignant,All Sites,D72.8,New code 2021+
9591/3/1,"Malignant lymphoma, non-Hodgkin, NOS",Malignant,All Sites,C85.1,
9596/3/1,"B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma  and classical Hodgkin lymphoma (C77_) (2010 ICD-O-3 update)",Malignant,All Sites,C83.3,
9597/3/1,Primary cutaneous follicle centre lymphoma (2010 ICD-O-3 update),Malignant,All Sites,C82.7,
9650/3/1,Classical Hodgkin lymphoma (ICD-O-3 update) (C77_),Malignant,All Sites,C81.9,
9651/3/1,Lymphocyte-rich classical Hodgkin lymphoma (C77_),Malignant,All Sites,C81.7,
9652/3/1,Mixed cellularity classical Hodgkin lymphoma (C77_),Malignant,All Sites,C81.2,
9653/3/1,Lymphocyte-depleted classical Hodgkin lymphoma (C77_) (2010 ICD-O-3 update),Malignant,All Sites,C81.3,
9654/3/1,"Hodgkin lymphoma, lymphocytic depletion, diffuse fibrosis [OBS] (C77_), (2010 ICD-O-3 update, see 9651/3)",Malignant,All Sites,C81.3,
9655/3/1,"Hodgkin lymphoma, lymphocyte depletion, reticular (C77_)",Malignant,All Sites,C81.3,
9659/3/1,Nodular lymphocyte predominant Hodgkin lymphoma (C77_),Malignant,All Sites,C81.0,
9661/3/1,"Hodgkin granuloma [OBS], (C77_), (2010 ICD-O-3 update, see 9650/3)",Malignant,All Sites,C81.7,
9662/3/1,"Hodgkin sarcoma [OBS] (C77_), (2010 ICD-O-3 update, see 9650/3)",Malignant,All Sites,C81.7,
9663/3/1,Nodular sclerosis classical Hodgkin lymphoma (C77_),Malignant,All Sites,C81.1,
9664/3/1,"Hodgkin lymphoma, nodular sclerosis, cellular phase [OBS],  (C77_), (2010 ICD-O-3 update, see 9663/3)",Malignant,All Sites,C81.1,
9665/3/1,"Hodgkin lymphoma, nodular sclerosis, grade 1 [OBS],  (C77_), (2010 ICD-O-3 update, see 9663/3)",Malignant,All Sites,C81.1,
9667/3/1,"Hodgkin lymphoma, nodular sclerosis, grade 2 [OBS] (C77_), (2010 ICD-O-3 update, see 9663/3)",Malignant,All Sites,C81.1,
9670/3/1,"Malignant lymphoma, small B lymphocytes, NOS [OBS], see 9823/3 (2010 ICD-O-3 update)",Malignant,All Sites,C83.0,
9671/3/1,Lymphoplasmacytic lymphoma,Malignant,All Sites,C88.0,
9673/1/1,In situ mantle cell neoplasia (ICD-O-3.2 update),Borderline,All Sites,D47.7,New code 2021+
9673/3/1,Mantle cell lymphoma,Malignant,All Sites,C83.1,
9675/3/1,"Malignant lymphoma, mixed small and large cell, diffuse [OBS], (2010 ICD-O-3 update, see 9690/3)",Malignant,All Sites,C83.2,
9678/3/1,Primary effusion lymphoma,Malignant,All Sites,C83.8,
9679/3/1,"Primary mediastinal (thymic) large B-cell lymphoma (C379, C38.3)",Malignant,All Sites,C83.8,
9680/1/1,EBV positive mucocutaneous ulcer (ICD-O-3.2 update),Borderline,All Sites,D47.7,New code 2021+
9680/3/1,Diffuse large B-cell lymphoma (DLBCL),Malignant,All Sites,C83.3,
9684/3/1,"Malignant lymphoma, large B-cell, diffuse, immunoblastic, NOS [OBS], (2010 ICD-O-3 update, see 9680/3)",Malignant,All Sites,C83.4,
9687/3/1,Burkitt lymphoma,Malignant,All Sites,C83.7,
9688/3/1,T-cell histiocyte-rich large B-cell lymphoma (C77_),Malignant,All Sites,C83.3,
9689/3/1,Splenic marginal zone lymphoma (C422),Malignant,All Sites,C83.0,
9690/3/1,Follicular lymphoma,Malignant,All Sites,C82.9,
9691/3/1,"Follicular lymphoma, grade 2",Malignant,All Sites,C82.1,
9695/1/1,In situ follicular neoplasia (ICD-O-3.2 update),Borderline,All Sites,D47.7,New code 2021+
9695/3/1,"Follicular lymphoma, grade 1",Malignant,All Sites,C82.0,
9698/3/1,"Follicular lymphoma, grade 3",Malignant,All Sites,C82.2,
9699/3/1,Extranodal marginal zone lymphoma of mucosal-associated lymphoid tissue (MALT lymphoma),Malignant,All Sites,C83.0,
9700/3/1,Mycosis fungoides (C44_),Malignant,All Sites,C84.0,
9701/3/1,Sezary syndrome (C44_),Malignant,All Sites,C84.1,
9702/1/1,Indolent T-cell lymphoproliferative disorder of the gastrointestina tract (ICD-O-3.2 update),Borderline,All Sites,D47.7,New code 2021+
9702/3/1,"Peripheral T-cell lymphoma, NOS",Malignant,All Sites,C84.4,
9705/3/1,Angioimmunoblastic T-cell lymphoma,Malignant,All Sites,C84.5,
9708/3/1,Subcutaneous panniculitis-like T-cell lymphoma (C49_),Malignant,All Sites,C84.5,
9709/1/1,Primary cutaneous CD4-positive small/medium T-cell lymphoproliferative disorder (ICD-O-3.2 update),Borderline,All Sites,D47.7,New code 2021+
9709/3/1,"Primary cutaneous T-cell lymphoma (C44_) (ICD-O-3.2 update, alternate name removed, see 9709/1)",Malignant,All Sites,C84.5,
9712/3/1,Intravascular large B-cell lymphoma (2010 ICD-O-3 update),Malignant,All Sites,C83.8,
9714/3/1,"Anaplastic large cell lymphoma, ALK-positive",Malignant,All Sites,C84.5,
9715/3/1,"Anaplastic large cell lymphoma, ALK-negative (ICD-O-3.2 update)",Malignant,All Sites,C84.5,New code 2021+
9716/3/1,Hepatosplenic T-cell lymphoma (C422),Malignant,All Sites,C84.5,
9717/3/1,Enteropathy-associated T-cell lymphoma,Malignant,All Sites,C84.5,
9718/1/1,Primary cutaneous CD30+ T-cell lymphoproliferative disorder  (C44_) (ICD-O-3.2 update),Borderline,All Sites,D47.7,New code 2021+
9718/3/1,"Primary cutaneous CD30-positive T-cell lymphoproliferative disorders (C44_) (ICD-O-3.2 update, alternate name removed, see 9718/1)",Malignant,All Sites,C84.4,
9719/3/1,"Extranodal NK--/T-cell lymphoma, nasal type",Malignant,All Sites,C84.5,
9724/3/1,Systemic EBV-positive T-cell lymphoproliferative disease of childhood (2010 ICD-O-3 update),Malignant,All Sites,C84.5,
9725/1/1,Hydroa vacciniforme-like lymphoma (C44_) (ICD-O-3.2 update),Borderline,All Sites,D47.7,New code 2021+
9725/3/1,"Hydroa vacciniforme-like lymphoma (C44_) (ICD-O-3.2 update, see 9725/1)",Malignant,All Sites,C84.5,
9726/3/1,"Primary cutaneous gamma delta T-cell lymphoma  (C44_, C49_) (2010 ICD-O-3 update)",Malignant,All Sites,C84.4,
9727/3/1,Blastic plasmacytoid dendritic cell neoplasm,Malignant,All Sites,C85.7,
9728/3/1,"Precursor B-lymphoblastic lymphoma [OBS], (2010 ICD-O-3 update, see 9811/3)",Malignant,All Sites,C83.5,
9729/3/1,"Precursor T--cell lymphoblastic lymphoma, NOS [OBS], (2010 ICD-O-3 update, see 9837/3)",Malignant,All Sites,C83.5,
9731/3/1,"Solitary plasmacytoma of bone (C40_, C41_)",Malignant,All Sites,C90.2,
9732/3/1,Plasma cell myeloma (C421),Malignant,All Sites,C90.0,
9733/3/1,"Plasma cell leukemia [OBS], (C421) (2010 ICD-O-3 update, see 9732/3)",Malignant,All Sites,C90.1,
9734/3/1,Extraosseous plasmacytoma,Malignant,All Sites,C90.2,
9735/3/1,Plasmablastic lymphoma (2010 ICD-O-3 update),Malignant,All Sites,C83.3,
9737/3/1,ALK-positive large B-cell lymphoma,Malignant,All Sites,C83.3,
9738/1/1,HHV8-positive germinotrophic-lymphoproliferative disorder (ICD-O-3.2 update),Borderline,All Sites,D47.7,New code 2021+
9738/3/1,Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease (2010 ICD-O-3 update),Malignant,All Sites,C83.3,
9740/1/1,Solitary mastocytoma of skin,Borderline,All Sites,D47.0,
9740/3/1,Mast cell sarcoma,Malignant,All Sites,C96.2,
9741/1/1,Indolent systemic mastocytosis,Borderline,All Sites,D47.0,New code 2021+
9741/3/1,Systemic mastocytosis (C421),Malignant,All Sites,C96.2,
9742/3/1,Mast cell leukemia (C421),Malignant,All Sites,C94.3,
9749/1/1,Juvenile xanthogranuloma (C715) (2023 update),Borderline,All Sites,D76.3,New code 2023+
9749/3/1,Erdheim-Chester disease (ICD-O-3.2 update),Malignant,All Sites,C96.2,New code 2021+
9750/3/1,"Malignant histiocytosis [OBS], (2010 ICD-O-3 update, see 9751/3)",Malignant,All Sites,C96.1,
9751/1/1,"Langerhans cell histiocytosis, NOS (ICD-O-3.2 update)",Borderline,All Sites,D76.0,New code 2021+
9751/3/1,"Langerhans cell histiocytosis (ICD-O-3.2 update, alternate names moved to 9751/1)",Malignant,All Sites,C96.0,
9752/1/1,"Langerhans cell histiocytosis, unifocal [OBS], (2010 ICD-O-3 update, see 9751/3)",Borderline,All Sites,D76.0,
9753/1/1,"Langerhans cell histiocytosis, multifocal [OBS], (2010 ICD-O-3 update, see 9751/3)",Borderline,All Sites,D76.0,
9754/3/1,"Langerhans cell histiocytosis, disseminated [OBS], (2010 ICD-O-3 update, see 9751/3)",Malignant,All Sites,C96.0,
9755/3/1,Histiocytic sarcoma,Malignant,All Sites,C96.3,
9756/3/1,Langerhans cell sarcoma,Malignant,All Sites,C96.7,
9757/3/1,Interdigitating dendritic cell sarcoma,Malignant,All Sites,C96.7,
9758/3/1,Follicular dendritic cell sarcoma,Malignant,All Sites,C96.7,
9759/3/1,Fibroblastic reticular cell tumor (2010 ICD-O-3 update),Malignant,All Sites,C96.7,
9760/3/1,"Immunoproliferative disease, NOS [OBS] (2010 ICD-O-3 update, see 9762/3)",Malignant,All Sites,C88.9,
9761/1/1,IgM monoclonal gammopathy of undetermined significance (ICD-O-3.2 update),Borderline,All Sites,D47.2,New code 2021+
9761/3/1,Waldenstrom macroglobulinemia (C421),Malignant,All Sites,C88.0,
9762/3/1,Heavy chain disease,Malignant,All Sites,C88.1,
9764/3/1,"Immunoproliferative small intestinal disease [OBS], (2010 ICD-O-3 update, see 9762/3)",Malignant,All Sites,C88.3,
9765/1/1,Monoclonal gammopathy of undetermined significance,Borderline,All Sites,D47.2,
9766/1/1,Angiocentric immunoproliferative lesion,Borderline,All Sites,D47.9,
9766/3/1,"Lymphomatoid granulomatosis, grade 3 (ICD-O-3.2 update)",Malignant,All Sites,C83.8,New code 2021+
9767/1/1,Angioimmunoblastic lymphadenopathy,Borderline,All Sites,D47.7,
9768/1/1,T gamma-lymphoproliferative disease,Borderline,All Sites,D47.7,
9769/1/1,Immunoglobulin deposition disease,Borderline,All Sites,D47.7,
9769/3/1,"Immunoglobulin deposition disease, malignant",Malignant,All Sites,C88.8,Not listed in ICD-O-3.2
9800/3/1,"Leukemia, NOS (C421)",Malignant,All Sites,C95.9,
9801/3/1,Acute undifferentiated leukemia (C421),Malignant,All Sites,C95.0,
9805/3/1,"Acute biphenotypic leukemia [OBS] (C421), (2010 ICD-O-3 update, see codes 9806/3-9809/3)",Malignant,All Sites,C95.0,
9806/3/1,Mixed phenotype acute leukemia with t(9;22)(q34;q11.2);BCR-ABL1  (C421) (2010 ICD-O-3 update),Malignant,All Sites,C95.0,
9807/3/1,Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged (C421) (2010 ICD-O-3 update),Malignant,All Sites,C95.0,
9808/3/1,"Mixed phenotype acute leukemia, B/myeloid, NOS (C421) (2010 ICD-O-3 update)",Malignant,All Sites,C95.0,
9809/3/1,"Mixed phenotype acute leukemia, T/myeloid, NOS (C421) (2010 ICD-O-3 update)",Malignant,All Sites,C95.0,
9811/3/1,"B lymphoblastic leukemia/lymphoma, NOS (2010 ICD-O-3 update)",Malignant,All Sites,C91.0,
9812/3/1,B Lymphoblastic leukemia/lymphoma with t(9;22)(q34;q11.2); BCR-ABL1 (2010 ICD-O-3 update),Malignant,All Sites,C91.0,
9813/3/1,B Lymphoblastic leukemia/lymphoma with t(v;11q23); MLL rearranged (2010 ICD-O-3 update),Malignant,All Sites,C91.0,
9814/3/1,B Lymphoblastic leukemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1) (2010 ICD-O-3 update),Malignant,All Sites,C91.0,
9815/3/1,B Lymphoblastic leukemia/lymphoma with hyperdiploidy (2010 ICD-O-3 update),Malignant,All Sites,C91.0,
9816/3/1,B Lymphoblastic leukemia/lymphoma with hypodiploidy (Hypodiploid ALL) (2010 ICD-O-3 update),Malignant,All Sites,C91.0,
9817/3/1,B Lymphoblastic leukemia/lymphoma with t(5;14)(q31;q32); IL3-IGH (2010 ICD-O-3 update),Malignant,All Sites,C91.0,
9818/3/1,B Lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3);E2A-PBX1 (TCF3-PBX1) (2010 ICD-O-3 update),Malignant,All Sites,C91.0,
9819/3/1,"B Lymphoblastic leukemia/lymphoma, BCR-ABL1-like (ICD-O-3.2 update)",Malignant,All Sites,C91.0,New code 2021+
9820/3/1,"Lymphoid leukemia, NOS (C421)",Malignant,All Sites,C91.9,
9823/1/1,"Monoclonal B-cell lymphocytosis, CLL type (ICD-O-3.2 update)",Borderline,All Sites,D72.8,New code 2021+
9823/3/1,Chronic lymphocytic leukemia/small lymphocytic lymphoma,Malignant,All Sites,C91.1,
9826/3/1,"Burkitt cell leukemia [OBS] (2021 ICD-O-3 update, see 9687/3) (C421) (",Malignant,All Sites,C91.7,
9827/3/1,Adult T-cell leukemia/lymphoma,Malignant,All Sites,C91.5,
9831/3/1,T-cell large granular lymphocytic leukemia (C421),Malignant,All Sites,C91.7,
9832/3/1,"Prolymphocytic leukemia, NOS (C421)",Malignant,All Sites,C91.3,
9833/3/1,B-cell prolymphocytic leukemia (C421),Malignant,All Sites,C91.3,
9834/3/1,T-cell prolymphocytic leukemia (C421),Malignant,All Sites,C91.3,
9835/3/1,"Precursor cell lymphoblastic leukemia, NOS [OBS} (C421) (2010 ICD-O-3 update, see 9811/3)",Malignant,All Sites,C91.0,
9836/3/1,"Precursor B-cell lymphoblastic leukemia [OBS} (C421) (2010 ICD-O-3 update, see code 9811/3)",Malignant,All Sites,C91.0,
9837/3/1,T lymphoblastic leukemia/lymphoma,Malignant,All Sites,C91.0,
9840/3/1,Acute erythroid leukemia (C421),Malignant,All Sites,C94.0,
9860/3/1,"Myeloid leukemia, NOS (C421)",Malignant,All Sites,C92.9,
9861/3/1,"Acute myeloid leukemia, NOS (C421)",Malignant,All Sites,C92.0,
9863/3/1,"Chronic myeloid leukemia, NOS (C421)",Malignant,All Sites,C92.1,
9865/3/1,Acute myeloid leukemia with t(6;9)(p23;q34);DEK-NUP214 (C421) (2010 ICD-O-3 update),Malignant,All Sites,C92.0,
9866/3/1,Acute promyelocytic leukemia (AML with t(15;17)(q22;q12)) PML/RARA (C421),Malignant,All Sites,C92.4,
9867/3/1,Acute myelomonocytic leukemia (C421),Malignant,All Sites,C92.5,
9869/3/1,Acute myeloid leukemia with inv(3)(q21;q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1 (C421) (2010 ICD-O-3 update),Malignant,All Sites,C92.0,
9870/3/1,Acute basophilic leukemia (C421),Malignant,All Sites,C92.0,
9871/3/1,"Acute myeloid leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22), CBFB-MYH11 (C421) (2010 ICD-O-3 update)",Malignant,All Sites,C92.0,
9872/3/1,Acute myeloid leukemia with minimal differentiation (C421),Malignant,All Sites,C92.0,
9873/3/1,Acute myeloid leukemia without maturation (C421),Malignant,All Sites,C92.0,
9874/3/1,Acute myeloblastic leukemia with maturation (C421),Malignant,All Sites,C92.0,
9875/3/1,"Chronic myelogenous leukemia, BCR/ABL1 positive (C421)",Malignant,All Sites,C92.1,
9876/3/1,"Atypical chronic myeloid leukemia, BCR-ABL1 negative (C421)",Malignant,All Sites,C92.1,
9877/3/1,Acute myeloid leukemia with mutated NPM1  (C421) (ICD-O-3.2 update),Malignant,All Sites,C92.0,New code 2021+
9878/3/1,Acute myeloid leukemia with biallelic mutation of CEBPA (C421) (ICD-O-3.2 update),Malignant,All Sites,C92.0,New code 2021+
9879/3/1,Acute myeloid leukemia with mutated RUNX1 (C421)  (ICD-O-3.2 update),Malignant,All Sites,C92.0,New code 2021+
9891/3/1,Acute monoblastic and monocytic leukemia,Malignant,All Sites,C93.0,
9895/3/1,Acute myeloid leukemia with myelodysplasia-related changes (C421),Malignant,All Sites,C92.0,
9896/3/1,"Acute myeloid leukemia, t(8;21)(q22;q22) RUNX1-RUNX1T1 (C421)",Malignant,All Sites,C92.0,
9897/3/1,Acute myeloid leukemia with t(9;11)(p22;q23);MLLT3-MLL (C421),Malignant,All Sites,C92.0,
9898/1/1,Transient abnormal myelopoiesis (C421) (2010 ICD-O-3 update),Borderline,All Sites,D47.7,
9898/3/1,Myeloid leukemia with Down Syndrome (C421) (2010 ICD-O-3 update),Malignant,All Sites,C92.0,
9910/3/1,Acute megakaryoblastic leukemia (C421),Malignant,All Sites,C94.2,
9911/3/1,Acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1  (C421) (2010 ICD-O-3 update),Malignant,All Sites,C92.0,
9912/3/1,Acute myeloid leukemia with BCR-ABL1 (C421) (ICD-O-3.2 update),Malignant,All Sites,C92.0,New code 2021+
9920/3/1,Therapy-related myeloid neoplasm (C421),Malignant,All Sites,C92.0,
9930/3/1,Myeloid sarcoma,Malignant,All Sites,C92.3,
9931/3/1,Acute panmyelosis with myelofibrosis (C421),Malignant,All Sites,C94.5,
9940/3/1,Hairy cell leukemia (C421),Malignant,All Sites,C91.4,
9945/3/1,Chronic myelomonocytic leukemia (C421),Malignant,All Sites,C93.1,
9946/3/1,Juvenile myelomonocytic leukemia (C421),Malignant,All Sites,C93.1,
9948/3/1,Aggressive NK-cell leukemia (C421),Malignant,All Sites,C94.7,
9950/3/1,Polycythemia vera (C421),Malignant,All Sites,D45,
9960/3/1,"Chronic myeloproliferative disease, NOS [OBS]  (C421), (2010 ICD-O-3 update, see 9975/3)",Malignant,All Sites,D47.1,
9961/3/1,Primary myelofibrosis (C421),Malignant,All Sites,D47.1,
9962/3/1,Essential thrombocythemia (C421),Malignant,All Sites,D47.3,
9963/3/1,Chronic neutrophilic leukemia  (C421),Malignant,All Sites,D47.1,
9964/3/1,"Chronic eosinophilic leukemia, NOS (C421)",Malignant,All Sites,D47.1,
9965/3/1,Myeloid and lymphoid neoplasms with PDGFRA rearrangement (C421) (2010 ICD-O-3 update),Malignant,All Sites,C96.7,
9966/3/1,Myeloid neoplasms with PDGFRB rearrangement (C421) (2010 ICD-O-3 update),Malignant,All Sites,C96.7,
9967/3/1,Myeloid and lymphoid neoplasms with FGFR1 (C421) (2010 ICD-O-3 update),Malignant,All Sites,C96.7,
9968/3/1,Myeloid or lymphoid neoplasm with PCM1-JAK2 (C421) (ICD-O-3.2 update),Malignant,All Sites,C96.7,New code 2021+
9970/1/1,"Lymphoproliferative disorder, NOS",Borderline,All Sites,D47.9,
9970/3/1,"Lymphoproliferative disease, malignant, NOS",Malignant,All Sites,C96.7,Not listed in ICD-O-3.2
9971/1/1,"Post transplant lymphoproliferative disorder, NOS (ICD-O-3.2 update)",Borderline,All Sites,D47.7,
9971/3/1,"Post transplant lymphoproliferative disorder  (ICD-O-3.2 update, see code 9971/1)",Malignant,All Sites,D47.7,Valid 2010-2020 only
9975/3/1,Myeloproliferative neoplasm unclassifiable  (C421) (2010 ICD-O-3 update),Malignant,All Sites,D47.1,
9980/3/1,Myelodysplastic syndrome with single lineage dysplasia (C421),Malignant,All Sites,D46.0,
9982/3/1,Myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia,Malignant,All Sites,D46.1,
9983/3/1,Myelodysplastic syndrome with excess blasts (C421),Malignant,All Sites,D46.2,
9984/3/1,"Refractory anemia with excess blasts in transformation [OBS] (C421), (2010 ICD-O-3 update, see 9983/3)",Malignant,All Sites,D46.3,
9985/3/1,Refractory cytopenia with multilineage dysplasia (C421),Malignant,All Sites,D46.7,
9986/3/1,Myelodysplastic syndrome associated with isolated del(5q) (C421),Malignant,All Sites,D46.7,
9987/3/1,"Therapy related myelodysplastic syndrome, NOS [OBS] (C421), (2010 ICD-O-3 update, see 9920/3)",Malignant,All Sites,D46.7,
9989/3/1,"Myelodysplastic syndrome, NOS (C421)",Malignant,All Sites,D46.9,
9991/3/1,"Refractory neutropenia, [OBS] (C421) (ICD-O-3.2 update, see code 9980)",Malignant,All Sites,D46.0,Valid 2010-2020 only
9992/3/1,"Refractory thrombocytopenia, [OBS] (C421) (ICD-O-3.2 update, see code 9980)",Malignant,All Sites,D46.0,Valid 2010-2020 only
9993/3/1,Myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia (C421) (ICD-O-3.2 update),Malignant,All sites,D46.7,New code 2021+
8000/0,"Neoplasm, benign",Benign,Specific Sites,See Topo Table B Col E,
8001/0,"Tumor cells, benign",Benign,Specific Sites,See Topo Table B Col E,
8005/0,"Clear cell tumor, NOS",Benign,Specific Sites,See Topo Table B Col E,
8010/0,"Epithelial tumor, benign",Benign,Specific Sites,See Topo Table B Col E,
8011/0,"Epithelioma, benign",Benign,Specific Sites,See Topo Table B Col E,
8040/0,"Tumorlet, benign",Benign,Specific Sites,See Topo Table B Col E,
8050/0,"Papilloma, NOS",Benign,Specific Sites,See Topo Table B Col E,
8051/0,Verrucous papilloma,Benign,Specific sites,See Topo Table B Col E,
8052/0,"Squamous cell papilloma, NOS",Benign,Specific sites,See Topo Table B Col E,
8053/0,"Squamous cell papilloma, inverted",Benign,Specific sites,See Topo Table B Col E,
8054/0,Warty dyskeratoma (ICD-O-3.2 update),Benign,Specific Sites,See Topo Table B Col E,
8060/0,Squamous papillomatosis,Benign,Specific Sites,See Topo Table B Col E,
8070/0,Actinic kertosis (ICD-O-3.2 update),Benign,Specific Sites,See Topo Table B Col E,
8072/0,Large cell acanthoma (ICD-O-3.2 update),Benign,Specific Sites,See Topo Table B Col E,
8077/0,"Squamous intraepithelial neoplasia, low grade",Benign,Specific Sites,See Topo Table B Col E,
8084/0,Clear cell acanthoma (ICD-O-3.2 update),Benign,Specific Sites,See Topo Table B Col E,
8096/0,Intraepidermal epithelioma of Jadassohn  (C44_),Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8100/0,Trichoepithelioma  (C44_),Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8101/0,Trichofolliculoma (C44_),Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8102/0,Trichilemmoma (C44_),Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8103/0,"Pilar tumor (C44_) (ICD-O-3.2 update, see code 8103/1)",Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8104/0,Pilar sheath acanthoma (C44_) (ICD-O-3.2 update),Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8110/0,"Pilomatricoma, NOS (C44_)",Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8120/0,"Urothelial papilloma, NOS (C67_) (ICD-O-3.2 update, previously 8120/1)",Benign,"C679, All Other Sites","D30.3, See Topo Table B Col E",
8121/0,"Sinonasal papilloma, exophytic (C300, C31_) (ICD-O-3 update,  previously 8121/1)",Benign,"C300, C319, All Other Sites","D14.0, See Topo Table B Col E",
8140/0,"Adenoma, NOS (C619)",Benign,"C619, All Other Sites","N40, See Topo Table B Col E",
8144/0,"Adenoma, intestinal type (C16_) (ICD-O-3.2 update)",Benign,"C169, All Other Sites","D13.1, See Topo Table B Col E",
8146/0,Monomorphic adenoma,Benign,Specific Sites,See Topo Table B Col E,
8147/0,"Basal cell adenoma (C07_, C08_)",Benign,"C079, C089, All Other Sites","D11.9, See Topo Table B Col E",
8148/0,"Glandular intraepithelial neoplasia, low grade",Benign,Specific Sites,See Topo Table B Col E,
8149/0,Canalicular adenoma,Benign,Specific Sites,See Topo Table B Col E,
8150/0,"Pancreatic endocrine tumor, benign (C25_) (ICD-O-3.2 update, see code 8150/3)",Benign,"C259, All Other Sites","C25.9, See Topo Table B Col B",
8151/0,"Insulinoma, NOS (C254) (ICD-O-3.2 update, see code 8151/3)",Benign,"C254, All Other Sites","C25.9, See Topo Table B Col B",
8160/0,"Bile duct adenoma (C221, C240)",Benign,"C221, C240, All Other Sites","D13.4, D13.5, See Topo Table B, Col E",
8161/0,"Bile duct cystadenoma (C221, C240)",Benign,"C221, C240, All Other Sites","D13.4, D13.5, See Topo Table B, Col E",
8163/0,"Pancreatobiliary neoplasm, non-invasive (C25_)",Benign,"C259, All Other Sites","D13.6, See Topo Table B Col E",
8170/0,Liver cell adenoma (C220),Benign,"C220, All Other Sites","D13.4, See Topo Table B Col E",
8190/0,Trabecular adenoma,Benign,Specific Sites,See Topo Table B Col E,
8191/0,Embryonal adenoma,Benign,Specific Sites,See Topo Table B Col E,
8200/0,Eccrine dermal cylindroma (C44_),Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8202/0,Microcystic adenoma,Benign,Specific Sites,See Topo Table B Col E,
8204/0,Lactating adenoma (C50_),Benign,"C509, All Other Sites","D24, See Topo Table B Col E",
8210/0,"Adenomatous polyp, NOS",Benign,Specific Sites,See Topo Table B Col E,
8211/0,"Tubular adenoma, NOS",Benign,Specific Sites,See Topo Table B Col E,
8212/0,Flat adenoma,Benign,Specific Sites,See Topo Table B Col E,
8213/0,Serrated adenoma (C18_),Benign,"C189, All Other Sites","D12.6, See Topo Table B Col E",
8220/0,Adenomatous polyposis coli (C18_),Benign,"C189, All Other Sites","D12.6, See Topo Table B Col E",
8221/0,Multiple adenomatous polyps,Benign,Specific Sites,See Topo Table B Col E,
8250/0,Atypical adenomatous hyperplasia (C34_) (ICD-O-3.2 update),Benign,"C349, All Other Sites","D14.3, See Topo Table B Col E",
8251/0,Alveolar adenoma (C34_),Benign,"C349, All Other Sites","D14.3, See Topo Table B Col E",
8260/0,"Papillary adenoma, NOS",Benign,Specific Sites,See Topo Table B Col E,
8261/0,"Villous adenoma, NOS",Benign,Specific Sites,See Topo Table B Col E,
8263/0,"Tubulovillous adenoma, NOS",Benign,Specific Sites,See Topo Table B Col E,
8264/0,"Papillomatosis, glandular (C221, C240)",Benign,"C221, C240, All Other Sites","D13.4, D13.5, See Topo Table B, Col E",
8270/0,Chromophobe adenoma (C751),Benign,"C751, All Other Sites","D35.2, See Topo Table B Col E",
8271/0,Prolactinoma (C751),Benign,"C751, All Other Sites","D35.2, See Topo Table B Col E",
8272/0,"Pituitary adenoma, NOS (C751)",Benign,"C751, All Other Sites","D35.2, See Topo Table B Col E",
8280/0,Acidophil adenoma (C751),Benign,"C751, All Other Sites","D35.2, See Topo Table B Col E",
8281/0,Mixed acidophil-basophil adenoma (C751),Benign,"C751, All Other Sites","D35.2, See Topo Table B Col E",
8290/0,Oxyphillic adenoma (C739),Benign,"C739, All Other Sites","D34, See Topo Table B Col E",
8300/0,Basophil adenoma (C751),Benign,"C751, All Other Sites","D35.2, See Topo Table B Col E",
8310/0,Clear cell adenoma,Benign,Specific Sites,See Topo Table B Col E,
8313/0,Clear cell adenofibroma (C569),Benign,"C569, All Other Sites","D27, See Topo Table B Col E",
8321/0,Chief cell adenoma (C750),Benign,"C750, All Other Sites","D35.1, See Topo Table B Col E",
8322/0,Water-clear cell adenoma (C750),Benign,"C750, All Other Sites","D35.1, See Topo Table B Col E",
8323/0,Mixed cell adenoma,Benign,Specific Sites,See Topo Table B Col E,
8324/0,Lipoadenoma,Benign,Specific Sites,See Topo Table B Col E,
8325/0,Metanephric adenoma (C649),Benign,"C649, All Other Sites","D30.0, See Topo Table B Col E",
8330/0,Follicular adenoma (C739),Benign,"C739, All Other Sites","D34, See Topo Table B Col E",
8333/0,"Microfollicular adenoma, NOS (C739)",Benign,"C739, All Other Sites","D34, See Topo Table B Col E",
8334/0,Macrofollicular adenoma (C739),Benign,"C739, All Other Sites","D34, See Topo Table B Col E",
8336/0,"Hyalinizing trabecular adenoma (C739) (ICD-O-3.2 update, see code 8336/1)",Benign,"C739, All Other Sites","D34, See Topo Table B Col E",
8361/0,Juxtaglomerular tumor  (C649),Benign,"C649, All Other Sites","D30.0, See Topo Table B Col E",
8370/0,"Adrenal cortical adenoma, NOS (C740)",Benign,"C740, All Other Sites","D35.0, See Topo Table B Col E",
8371/0,"Adrenal cortical adenoma, compact cell (C740)",Benign,"C740, All Other Sites","D35.0, See Topo Table B Col E",
8372/0,"Adrenal cortical adenoma, pigmented (C740)",Benign,"C740, All Other Sites","D35.0, See Topo Table B Col E",
8373/0,"Adrenal cortical adenoma, clear cell (C740)",Benign,"C740, All Other Sites","D35.0, See Topo Table B Col E",
8374/0,"Adrenal cortical adenoma, glomerulosa cell (C740)",Benign,"C740, All Other Sites","D35.0, See Topo Table B Col E",
8375/0,"Adrenal cortical adenoma, mixed cell (C740)",Benign,"C740, All Other Sites","D35.0, See Topo Table B Col E",
8380/0,"Endometrioid adenoma, NOS (C541)",Benign,"C541, All Other Sites","D26.1, See Topo Table B Col E",
8381/0,"Endometrioid adenofibroma, NOS (C541)",Benign,"C541, All Other Sites","D26.1, See Topo Table B Col E",
8390/0,Skin appendage adenoma (C44_),Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8391/0,Follicular fibroma (C44_),Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8392/0,Syringofibroadenoma (C44_),Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8400/0,Sweat gland adenoma (C44_),Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8401/0,Apocrine adenoma (C44_),Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8402/0,"Hidradenoma, NOS (C44_)",Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8403/0,"Spiradenoma, NOS (C44_)",Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8404/0,Hidrocystoma (C44_),Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8405/0,Papillary hidradenoma,Benign,Specific Sites,See Topo Table B Col E,
8406/0,Syringocystadenoma papilliferum (C44_),Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8407/0,"Syringoma, NOS (C44_)",Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8408/0,Eccrine papillary adenoma (C44_),Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8409/0,"Poroma, NOS (C44_)",Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8410/0,Sebaceoma (C44_),Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8420/0,Ceruminous adenoma (C442),Benign,"C442, All Other Sites","D23.2, See Topo Table B Col E",
8440/0,"Cystadenoma, NOS",Benign,Specific Sites,See Topo Table B Col E,
8441/0,"Serous cystadenoma, NOS (C569) (ICD-O-3 update, 8460/0 moved to this code)",Benign,"C569, All Other Sites","D27, See Topo Table B Col E",
8443/0,Clear cell cystadenoma (C569),Benign,"C569, All Other Sites","D27, See Topo Table B Col E",
8450/0,"Papillary cystadenoma, NOS",,"C569, All Other Sites","D27, See Topo Table B Col E",
8453/0,Intraductal Papillary mucinous adenoma (C25_),Benign,"C259, All Other Sites","D13.6, See Topo Table B Col E",
8454/0,Cystic tumor of atrio-ventricular node (C380),Benign,"C380, All Other Sites","D15.1, See Topo Table B Col E",
8461/0,Serous surface papilloma (C569),Benign,"C569, All Other Sites","D27, See Topo Table B Col E",
8470/0,"Mucinous cystadenoma (C569)  (ICD-O-3 update, now includes 8471/0)",Benign,"C569, All Other Sites","D27, See Topo Table B Col E",
8471/0,"Papillary mucinous cystadenoma, NOS (C569) (ICD-O-3.2 update, see code 8470/0)",Benign,"C569, All Other Sites","D27, See Topo Table B Col E",
8474/0,Seromucinous cystadenoma (ICD-O-3.2 update) (C569),Benign,"C569, All Other Sites","D27, See Topo Table B Col E",New code 2021+
8480/0,Mucinous adenoma,Benign,Specific Sites,See Topo Table B Col E,
8503/0,Intraductal papilloma,Benign,Specific Sites,See Topo Table B Col E,
8504/0,Intracystic papillary adenoma,Benign,Specific Sites,See Topo Table B Col E,
8505/0,"Intraductal papillomatosis, NOS",Benign,Specific Sites,See Topo Table B Col E,
8506/0,Adenoma of nipple (C50_),Benign,"C509, All Other Sites","D24, See Topo Table B Col E",
8550/0,Acinar cell adenoma,Benign,Specific Sites,See Topo Table B Col E,
8560/0,Mixed squamous cell and glandular papilloma,Benign,Specific Sites,See Topo Table B Col E,
8561/0,"Adenolymphoma (C07_, C08_)",Benign,"C079, C089, All Other Sites","D11.9, See Topo Table B Col E",
8563/0,Lymphadenoma (ICD-O-3.2 update),Benign,Specific Sites,See Topo Table B Col E,
8572/0,Adenoma with spindle cell metaplasia,Benign,Specific Sites,See Topo Table B Col E,Not listed in ICD-O-3.2
8580/0,Microscopic thymoma,Benign,"C379, All Other Sites","D15.0, See Topo Table B Col E",
8587/0,Ectopic hamartomatous thymoma,Benign,Specific Sites,See Topo Table B Col E,
8590/0,Sex cord-stromal tumor benign (ICD-O-3.2 update),Benign,Specific Sites,See Topo Table B Col E,New code 2021+
8600/0,"Thecoma, NOS (C569)",Benign,"C569, All Other Sites","D27, See Topo Table B Col E",
8601/0,"Thecoma, luteinized (C569)",Benign,"C569, All Other Sites","D27, See Topo Table B Col E",
8602/0,Sclerosing stromal tumor (C569),Benign,"C569, All Other Sites","D27, See Topo Table B Col E",
8610/0,"Luteoma, NOS (C569)",Benign,"C569, All Other Sites","D27, See Topo Table B Col E",
8622/0,"Granulosa cell tumor of the testis, juvenile C62_) (ICD-O-3.2 update)",Benign,"C629, All Other Sites","D29.2, See Topo Table B Col E",
8630/0,"Androblastoma, benign  (C569 [F], C62_[M])",Benign,"C569 [F], C629 [M], All Other Sites","D27.0 [F], D29.2 [M], See Topo Table B Col E",
8631/0,"Sertoli-Leydig cell tumor, well differentiated (C569 [F], C62_[M])",Benign,"C569 [F], C629 [M], All Other Sites","D27.0 [F], D29.2 [M], See Topo Table B Col E",
8641/0,"Sertoli cell tumor with lipid storage  (C569 [F], C62_[M])",Benign,"C569 [F], C629 [M], All Other Sites","D27.0 [F], D29.2 [M], See Topo Table B Col E",
8650/0,"Leydig cell tumor of ovary, NOS (ICD-O-3.2 update) (C569)",Benign,"C569, All Other Sites","D27, See Topo Table B Col E",
8660/0,Hilus cell tumor (C569),Benign,"C569, All Other Sites","D27, See Topo Table B Col E",
8670/0,Lipid cell tumor of ovary (C569),Benign,"C569, All Other Sites","D27, See Topo Table B Col E",
8671/0,Adrenal rest tumor,Benign,Specific Sites,See Topo Table B Col E,
8680/0,"Paraganglioma, benign (C755) (ICD-O-3.2 update, see code 8680/3)",Benign,"C755, All Other Sites","D35.6, See Topo Table B Col E",
8683/0,Gangliocytic paraganglioma (C170),Benign,"C170, All Other Sites","D13.2, See Topo Table B Col E",
8700/0,"Pheochromocytoma, NOS (C741) (ICD-O-3.2 update, see code 8700/3)",Benign,"C741, All Other Sites","D35.0, See Topo Table B Col E",
8711/0,"Glomus tumor, NOS",Benign,All Sites,D18.0,
8712/0,Glomangioma,Benign,All Sites,D18.0,
8713/0,Glomangiomyoma,Benign,All Sites,D18.0,
8714/0,"Perivascular epithelioid tumor, benign (ICD-O-3.2 update)",Benign,Specific Sites,See Topo Table B Col E,
8720/0,"Pigmented nevus, NOS (C44_)",Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8722/0,Balloon cell nevus (C44_),Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8723/0,Halo nevus C44_),Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8725/0,Neuronevus (C44_),Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8726/0,Magnocellular nevus (C694),Benign,"C694, All Other Sites","D31.4, See Topo Table B Col E",
8727/0,Dysplastic nevus ( C44_),Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8728/0,Meningeal melanocytosis (C70_),Benign,"C709, All Other Sites","D32.9, See Topo Table B Col E",
8730/0,Nonpigmented nevus (C44_),Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8740/0,"Junctional nevus, NOS (C44_)",Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8742/0,Lentiginous melanocytic nevus (C44_) (ICD-O-3.2 update),Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8744/0,Lentinguous melanocytic nevus (C44_) (ICD-O-3.2 update),Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8750/0,Dermal nevus (C44_),Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8760/0,Compound nevus (C44_),Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8761/0,"Congenital melanocytic nevus, NOS (C44_)",Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8770/0,Epithelioid and spindle cell nevus (C44_),Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8771/0,Epithelioid cell nevus (C44_),Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8772/0,"Spindle cell nevus, NOS (C44_)",Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8780/0,"Blue nevus, NOS (C44_)",Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8790/0,Cellular blue nevus  (C44_),Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8800/0,"Soft tissue tumor, benign (C49_)",Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
8810/0,"Fibroma, NOS (C49_)",Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
8811/0,Fibromyxoma (C49_),Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
8812/0,"Periosteal fibroma (C40_, C41_)",Benign,"C409, C419, All Other Sites","D16.9, See Topo Table B Col E",
8813/0,Fibroma of tendon sheath,Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
8815/0,"Solitary fibrous tumor/Hemangiopericytoma, grade 1 (C49_) (ICD-O-3.2 update, see code 8815/1)",Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
8816/0,Calcifying aponeurotic fibroma (ICD-O-3.2 update),Benign,Specific Sites,See Topo Table B Col E,
8817/0,Calcifying fibrous tumor (ICD-O-3.2 update),Benign,Specific Sites,See Topo Table B Col E,
8818/0,Fibrous dysplasia (ICD-O-3.2 update),Benign,Specific Sites,See Topo Table B Col E,
8820/0,Elastofibroma (C49_),Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
8823/0,"Desmoplastic fibroma, benign (C49_) (ICD-O-3.2 update, see code 8823/1)",Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
8824/0,Myofibroma (C49_),Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
8825/0,Myofibroblastoma (C49_),Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
8826/0,Angiomyofibroblastoma (C49_),Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
8828/0,Nodular fascitis (ICD-O-3.2 update),Benign,Specific Sites,See Topo Table B Col E,
8830/0,Benign fibrous histiocytoma (C49_),Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
8831/0,"Histiocytoma, NOS (C49_)",Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
8832/0,"Dermatofibroma, NOS (C44_)",Benign,"C449, All Other Sites","D23.9, See Topo Table B Col E",
8840/0,"Myxoma, NOS (C49_)",Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
8841/0,"Angiomyxoma, NOS (C49_) (ICD-O-3.2 update, previously 8841/1)",Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
8842/0,"Ossifying fibromyxoid tumor, NOS",Benign,Specific Sites,See Topo Table B Col E,
8850/0,"Lipoma, NOS (C49_)",Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
8851/0,Fibrolipoma (C49_),Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
8852/0,Fibromyxolipoma (C49_),Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
8854/0,Pleomorphic lipoma (C49_),Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
8856/0,Intramuscular lipoma (C49_),Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
8857/0,Spindle cell lipoma (C49_),Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
8860/0,Angiomyolipoma (C49_),Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
8861/0,"Angiolipoma, NOS",Benign,Specific Sites,See Topo Table B Col E,
8862/0,Chondroid lipoma,Benign,Specific Sites,See Topo Table B Col E,
8870/0,Myelolipoma,Benign,Specific Sites,See Topo Table B Col E,
8880/0,Hibernoma,Benign,Specific Sites,See Topo Table B Col E,
8881/0,Lipoblastomatosis,Benign,Specific Sites,See Topo Table B Col E,
8890/0,"Leiomyoma, NOS (C54_)",Benign,"C549, All Other Sites","D26.0, See Topo Table B Col E",
8891/0,Epithelioid leiomyoma (C49_),Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
8892/0,Cellular leiomyoma (C49_),Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
8893/0,Bizarre leiomyoma (C49_),Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
8894/0,Angiomyoma (C49_),Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
8895/0,Myoma (C49_),Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
8896/0,Myxoid leiomyoma (C49_) (ICD-O-3.2 update),Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
8900/0,"Rhabdomyoma, NOS (C49_)",Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
8903/0,Fetal rhabdomyoma (C49_),Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
8904/0,Adult cellular rhabdomyoma (C49_),Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
8905/0,"Genital rhabdomyoma (C51_, C529)",Benign,"C519, C529, All Other Sites","D28.0, D28.2, See Topo Table B Col E",
8930/0,Endometrial stromal nodule (C541),Benign,"C541, All Other Sites","D26.1, See Topo Table B Col E",
8932/0,Adenomyoma,Benign,Specific Sites,See Topo Table B Col E,
8935/0,"Stromal tumor, benign (C541)",Benign,"C541, All Other Sites","D26.1, See Topo Table B Col E",
8936/0,"Gastrointestinal stromal tumor, benign (C269) (ICD-O-3.2 update, code deleted, see 8936/3)",Benign,"C269, Specific Sites","D13.9, See Topo Table B Col E",
8940/0,"Pleomorphic adenoma (C07_, C08_)",Benign,"C079, C089, All Other Sites","D11.9, See Topo Table B Col E",
8959/0,Benign cystic nephroma (C649),Benign,"C649, All Other Sites","D30.0, See Topo Table B Col E",
8965/0,"Nephrogenic adenofibroma (C649) (ICD-O-3.2 update, see code 9013/0)",Benign,"C649, All Other Sites","D30.0, See Topo Table B Col E",
8966/0,Renomedullary interstitial cell tumor (C649),Benign,"C649, All Other Sites","D30.0, See Topo Table B Col E",
8967/0,Ossifying renal tumor (C649),Benign,"C649, All Other Sites","D30.0, See Topo Table B Col E",
8982/0,"Myoepithelioma, NOS",Benign,Specific Sites,See Topo Table B Col E,
8983/0,"Adenomyoepithelioma, NOS (C50_)",Benign,"C509, All Other Sites","D24, See Topo Table B Col E",
8990/0,"Mesenchymoma, benign (C49_)",Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
8992/0,Pulmonary hamartoma (ICD-O-3.2 update) (C34_),Benign,"C349, All Other Sites","D14.3, See Topo Table B Col E",New code 2021+
9000/0,"Brenner tumor, NOS (C569)",Benign,"C569, All Other Sites","D27, See Topo Table B Col E",
9010/0,"Fibroadenoma, NOS (C50_)",Benign,"C509, All Other Sites","D24, See Topo Table B Col E",
9011/0,Intracanalicular fibroadenoma  (C50_),Benign,"C509, All Other Sites","D24, See Topo Table B Col E",
9012/0,Pericanalicular fibroadenoma (C50_),Benign,"C509, All Other Sites","D24, See Topo Table B Col E",
9013/0,"Adenofibroma, NOS (C569)",Benign,"C569, All Other Sites","D27, See Topo Table B Col E",
9014/0,"Serous adenofibroma, NOS (C569)",Benign,"C569, All Other Sites","D27, See Topo Table B Col E",
9015/0,"Mucinous adenofibroma, NOS (C569)",Benign,"C569, All Other Sites","D27, See Topo Table B Col E",
9016/0,Giant fibroadenoma (C50_),Benign,"C509, All Other Sites","D24, See Topo Table B Col E",
9020/0,"Phyllodes tumor, benign (C50_)",Benign,"C509, All Other Sites","D24, See Topo Table B Col E",
9030/0,Juvenile fibroadenoma (C50_),Benign,"C509, All Other Sites","D24, See Topo Table B Col E",
9040/0,"Synovioma, benign (C49_)",Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
9050/0,"Mesothelioma, benign (C384)",Benign,"C384, All Other Sites","D19.0, See Topo Table B, Col E",
9051/0,"Fibrous mesothelioma, benign (C384)",Benign,"C384, All Other Sites","D19.0, See Topo Table B, Col E",
9052/0,Well differentiated papillary mesothelioma (C384),Benign,"C384, All Other Sites","D19.0, See Topo Table B, Col E",
9054/0,"Adenomatoid tumor, NOS (C384)",Benign,"C384, All Other Sites","D19.0, See Topo Table B, Col E",
9055/0,"Peritoneal inclusion cysts (C48_) (ICD-O-3 update, previously 9055/1)",Benign,"C488, All Other Sites","D21.0, See Topo Table B Col E",
9080/0,"Teratoma, benign",Benign,Specific Sites,See Topo Table B Col E,
9084/0,"Dermoid cyst, NOS",Benign,Specific Sites,See Topo Table B Col E,
9090/0,"Struma ovarii, NOS (C569)",Benign,"C569, All Other Sites","D27, See Topo Table B Col E",
9100/0,"Hydatidiform mole, NOS (C589)",Benign,"C589, All Other Sites","D26.7, See Topo Table B Col E",
9103/0,Partial hydatidiform mole (C589),Benign,"C589, All Other Sites","D26.7, See Topo Table B Col E",
9110/0,Adenoma of rete ovarii,Benign,Specific Sites,See Topo Table B Col E,
9120/0,"Hemangioma, NOS",Benign,All sites,D18.0,
9121/0,Cavernous hemangioma,Benign,All sites,D18.0,
9122/0,Venous hemangioma,Benign,All sites,D18.0,
9123/0,Racemose hemangioma,Benign,All sites,D18.0,
9125/0,Epithelioid hemangioma,Benign,All sites,D18.0,
9126/0,Atypical vascular lesion (ICD-O-3.2 update),Benign,Specific Sites,See Topo Table B Col E,
9130/0,"Hemangioendothelioma, benign",Benign,All sites,D18.0,
9131/0,Capillary hemangioma,Benign,All sites,D18.0,
9132/0,Intramuscular hemangioma,Benign,All sites,D18.0,
9137/0,Myointimoma (ICD-O-3.2 update),Benign,Specific Sites,See Topo Table B Col E,New code 2021+
9141/0,Angiokeratoma,Benign,All Sites,D18.0,
9142/0,Verrucous keratotic hemangioma,Benign,All Sites,D18.0,
9150/0,"Hemangiopericytoma, benign  (ICD-O-3.2 update, see code 8815/1)",Benign,All Sites,D18.0,
9160/0,"Angiofibroma, NOS",Benign,All Sites,D18.0,
9161/0,Acquired tufted hemangioma,Benign,All Sites,D18.0,
9170/0,"Lymphangioma, NOS",Benign,All Sites,D18.1,
9171/0,Capillary lymphangioma,Benign,All Sites,D18.1,
9172/0,Cavernous lymphangioma,Benign,All Sites,D18.1,
9173/0,Cystic lymphangioma,Benign,All Sites,D18.1,
9174/0,Lymphangiomyoma,Benign,All Sites,D18.1,
9175/0,Hemolymphangioma,Benign,All Sites,D18.1,
9180/0,"Osteoma, NOS (C40_, C41_)",Benign,"C409, C419, All Other Sites","D16.9, See Topo Table B Col E",
9191/0,"Osteoid osteoma (C40_, C41_)",Benign,"C409, C419, All Other Sites","D16.9, See Topo Table B Col E",
9200/0,"Osteoblastoma, NOS (C40_, C41_)",Benign,"C409, C419, All Other Sites","D16.9, See Topo Table B Col E",
9210/0,"Osteochondroma (C40_, C41_)",Benign,"C409, C419, All Other Sites","D16.9, See Topo Table B Col E",
9211/0,Osteochondromyxoma (ICD-O-3.2 update),Benign,Specific Sites,See Topo Table B Col E,New code 2021+
9212/0,Bizarre parosteal osteochondromatous proliferation (ICD-O-3.2 update),Benign,Specific Sites,See Topo Table B Col E,New code 2021+
9213/0,Subungal exostosis (ICD-O-3.2 update),Benign,Specific Sites,See Topo Table B Col E,
9220/0,"Chondroma, NOS (C40_, C41.)",Benign,"C409, C419, All Other Sites","D16.9, See Topo Table B Col E",
9221/0,"Periosteal chondroma (C40_, C41_)",Benign,"C409, C419, All Other Sites","D16.9, See Topo Table B Col E",
9230/0,"Chondroblastoma, NOS (C40_, C41_) (ICD-O-3.2 update, see code 9230/1)",Benign,"C409, C419, All Other Sites","D16.9, See Topo Table B Col E",
9241/0,"Chondromyxoid fibroma (C40_, C41_)",Benign,"C409, C419, All Other Sites","D16.9, See Topo Table B Col E",
9252/0,Tenosynovial giant cell tumor  (C49_),Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
9260/0,Aneurysmal bone cyst (ICD-O-3.2 update),Benign,"C409, C419, All Other Sites","D16.9, See Topo Table B Col E",
9262/0,"Ossifying fibroma (C40_, C41_)",Benign,"C409, C419, All Other Sites","D16.9, See Topo Table B Col E",
9270/0,"Odontogenic tumor, benign (C41_)",Benign,"C419, All Other Sites","D16.9, See Topo Table B Col E",
9271/0,Ameloblastic fibrodentinoma (C41_),Benign,"C419, All Other Sites","D16.9, See Topo Table B Col E",
9272/0,"Cementoma, NOS  (C41_)",Benign,"C419, All Other Sites","D16.9, See Topo Table B Col E",
9273/0,"Cementoblastoma, benign (C41_)",Benign,"C419, All Other Sites","D16.9, See Topo Table B Col E",
9274/0,Cemento-ossifying fibroma (C41_),Benign,"C419, All Other Sites","D16.9, See Topo Table B Col E",
9275/0,Gigantiform cementoma (C41_),Benign,"C419, All Other Sites","D16.9, See Topo Table B Col E",
9280/0,"Odontoma, NOS (C41_)",Benign,"C419, All Other Sites","D16.9, See Topo Table B Col E",
9281/0,Compound odontoma (C41_),Benign,"C419, All Other Sites","D16.9, See Topo Table B Col E",
9282/0,Complex odontoma (C41_),Benign,"C419, All Other Sites","D16.9, See Topo Table B Col E",
9290/0,Ameloblastic fibro-odontoma (C41_),Benign,"C419, All Other Sites","D16.9, See Topo Table B Col E",
9300/0,Adenomatoid odontogenic tumor  (C41_),Benign,"C419, All Other Sites","D16.9, See Topo Table B Col E",
9301/0,Calcifying odontogenic cyst (C41_),Benign,"C419, All Other Sites","D16.9, See Topo Table B Col E",
9302/0,Dentinogenic ghost cell tumor (C41_),Benign,"C419, All Other Sites","D16.9, See Topo Table B Col E",
9310/0,"Ameloblastoma, NOS (C41_)",Benign,"C419, All Other Sites","D16.9, See Topo Table B Col E",
9311/0,Odontoameloblastoma (C41_),Benign,"C419, All Other Sites","D16.9, See Topo Table B Col E",
9312/0,Squamous odontogenic tumor (C41_),Benign,"C419, All Other Sites","D16.9, See Topo Table B Col E",
9320/0,Odontogenic myxoma (C41_),Benign,"C419, All Other Sites","D16.9, See Topo Table B Col E",
9321/0,"Odontogenic fibroma, NOS (C41_)",Benign,"C419, All Other Sites","D16.9, See Topo Table B Col E",
9322/0,Peripheral odontogenic fibroma (C41_),Benign,"C419, All Other Sites","D16.9, See Topo Table B Col E",
9330/0,Ameloblastic fibroma (C41_),Benign,"C419, All Other Sites","D16.9, See Topo Table B Col E",
9340/0,Calcifying epithelial odontogenic tumor (C41_),Benign,"C419, All Other Sites","D16.9, See Topo Table B Col E",
9350/0,"Craniopharyngioma, benign (C752)",Benign,"C752, All Other Sites","D35.3, See Topo Table B Col E",Not listed in ICD-O-3.2
9351/0,"Craniopharyngioma, adamantinomatous, benign (C752)",Benign,"C752, All Other Sites","D35.3, See Topo Table B Col E",Not listed in ICD-O-3.2
9352/0,"Craniopharyngioma, papillary, benign (C752)",Benign,"C752, All Other Sites","D35.3, See Topo Table B Col E",Not listed in ICD-O-3.2
9360/0,"Pinealoma, benign (C753)",Benign,"C753, All Other Sites","D35.4, See Topo Table B Col E",Not listed in ICD-O-3.2
9363/0,"Melanotic neuroectodermal tumor (C40_, C41_)",Benign,"C409, C419, All Other Sites","D16.9, See Topo Table B Col E",
9370/0,Benign notochordal tumor (ICD-O-3.2 update),Benign,Specific Sites,See Topo Table B Col E,
9373/0,Parachordoma (C49_),Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
9380/0,"Glioma, benign (C71_)",Benign,"C719, All Other Sites","D33.2, See Topo Table B Col E",Not listed in ICD-O-3.2
9381/0,"Gliomatosis cerebri, benign (C71_)",Benign,"C719, All Other Sites","D33.2, See Topo Table B Col E",Not listed in ICD-O-3.2
9383/0,"Subependymoma, benign (C71_)",Benign,"C719, All Other Sites","D33.2, See Topo Table B Col E",Not listed in ICD-O-3.2
9384/0,"Supependymal giant cell astrocytoma, benign (C71_)",Benign,"C719, All Other Sites","D33.2, See Topo Table B Col E",Not listed in ICD-O-3.2
9390/0,"Choroid plexus papilloma, NOS (C715)",Benign,"C715, All Other Sites","D33.2, See Topo Table B Col E",
9391/0,"Ependymoma, benign (C71_)",Benign,"C719, All Other Sites","D33.2, See Topo Table B Col E",Not listed in ICD-O-3.2
9393/0,"Papillary ependymoma, benign (C71_)",Benign,"C719, All Other Sites","D33.2, See Topo Table B Col E",Not listed in ICD-O-3.2
9394/0,"Myxopapillary ependymoma, benign (C71_)",Benign,"C719, All Other Sites","D33.2, See Topo Table B Col E",Not listed in ICD-O-3.2
9400/0,"Astrocytoma, benign (C71_)",Benign,"C719, All Other Sites","D33.2, See Topo Table B Col E",Not listed in ICD-O-3.2
9401/0,"Astrocytoma, anaplastic, benign (C71_)",Benign,"C719, All Other Sites","D33.2, See Topo Table B Col E",Not listed in ICD-O-3.2
9411/0,"Gemistocytic astrocytoma, benign (C71_)",Benign,"C719, All Other Sites","D33.2, See Topo Table B Col E",Not listed in ICD-O-3.2
9413/0,Dysembryoplastic neuroepithelial tumor,Benign,Specific Sites,See Topo Table B Col E,
9440/0,"Glioblastoma, NOS, benign (C71_)",Benign,"C719, All Other Sites","D33.2, See Topo Table B Col E",Not listed in ICD-O-3.2
9450/0,"Oligodendroglioma, benign  (C71_)",Benign,"C719, All Other Sites","D33.2, See Topo Table B Col E",Not listed in ICD-O-3.2
9490/0,Ganglioneuroma  (C49_),Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
9491/0,Ganglioneuromatosis  (C49_),Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
9492/0,Gangliocytoma  (C49_),Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
9493/0,Dysplastic gangliocytoma of cerebellum (C716) (Lhermitte-Duclos),Benign,"C716, All Other Sites","D33.1, See Topo Table B Col E",
9500/0,"Neuroblastoma, NOS, benign",Benign,Specific Sites,See Topo Table B Col E,Not listed in ICD-O-3.2
9501/0,"Medulloepithelioma, benign (C694)",Benign,"C694, All Other Sites","D31.4, See Topo Table B Col E",
9502/0,"Teratoid medulloepithelioma, benign (C694)",Benign,"C694, All Other Sites","D31.4, See Topo Table B Col E",
9505/0,Multinodular and vascolating neuronal tumor (C712) (MVNT) (ICD-O-3.2 Update),Benign,"C712, All Other Sites","D33.0, See Topo Table B Col E",
9506/0,"Central neurocytoma, benign (C716)",Benign,"C716, All Other Sites","D33.1, See Topo Table B Col E",Not listed in ICD-O-3.2
9507/0,Pacinian tumor,Benign,Specific Sites,See Topo Table B Col E,
9509/0,Multinodlar and vacuolating neuronal tumor (C71_) (2023 update),Benign,"C719, All Other Sites","D33.1, See Topo Table B Col E",
9510/0,Retinocytoma (C692),Benign,"C692, All Other Sites","D31.2, See Topo Table B Col E",
9530/0,"Meningioma, NOS (C70_)",Benign,"C709, All Other Sites","D32.9, See Topo Table B Col E",
9531/0,Meningiothelial meningioma (C70_),Benign,"C709, All Other Sites","D32.9, See Topo Table B Col E",
9532/0,Fibrous meningioma (C70_),Benign,"C709, All Other Sites","D32.9, See Topo Table B Col E",
9533/0,Psammomatous meningioma (C70_),Benign,"C709, All Other Sites","D32.9, See Topo Table B Col E",
9534/0,Angiomatous meningioma (C70_),Benign,"C709, All Other Sites","D32.9, See Topo Table B Col E",
9535/0,Hemangioblastic meningioma [OBS] (C70_),Benign,"C709, All Other Sites","D32.9, See Topo Table B Col E",
9537/0,Transitional meningioma (C70_),Benign,"C709, All Other Sites","D32.9, See Topo Table B Col E",
9538/0,"Clear cell meningioma, benign (C70_)",Benign,"C709, All Other Sites","D32.9, See Topo Table B Col E",Not listed in ICD-O-3.2
9539/0,"Atypical meningioma, benign (C70_)",Benign,"C709, All Other Sites","D32.9, See Topo Table B Col E",Not listed in ICD-O-3.2
9540/0,"Neurofibroma, NOS",Benign,Specific Sites,See Topo Table B Col E,
9541/0,Melanotic neurofibroma,Benign,Specific Sites,See Topo Table B Col E,
9550/0,"Plexiform neurofibroma, NOS",Benign,Specific Sites,See Topo Table B Col E,
9560/0,"Schwannoma, NOS (ICD-O-3.2 update, see 9560/1)",Benign,Specific Sites,See Topo Table B Col E,
9562/0,Nerve sheath myxoma,Benign,Specific Sites,See Topo Table B Col E,
9563/0,"Nerve sheath tumor, NOS (ICD-O-3.2 update)",Benign,Specific Sites,See Topo Table B Col E,New code 2021+
9570/0,"Neuroma, NOS",Benign,Specific Sites,See Topo Table B Col E,
9571/0,"Perineurioma, benign, NOS",Benign,Specific Sites,See Topo Table B Col E,
9580/0,"Granular cell tumor, NOS (C49_)",Benign,"C499, All Other Sites","D21.9, See Topo Table B Col E",
9582/0,Granular cell tumor of the sellar region  (C751),Benign,"C751, All Other Sites","D35.2, See Topo Table B Col E",